[{"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "13 units", "code_info": "Rx #'s:    0398243    0394272      0383374    0396251      0365041      0409704    0406772    0406773    0399065    0384313", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TOBRAMYCIN 1.4% (14MG/ML) OPHTHALMIC\t15 ML  \t3 ML  \t  \t7 ML;  \t  \t  TOBRAMYCIN SOLUTION** 0.3% OPHTHALMIC\t30 MLS  \t  \t5 MLS;  TOBRAMYCIN SULFATE** (25X2ML) 80MG/2ML INJECTABLE\t100 ML  \t150 ML  \t50 MLS;  TOBRAMYCIN/AMPHOTERICIN-B/BUDESONIDE, STERILE 125MG/5MG/0.6MG/5ML NASO-NEB\t70 ML  (9 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1627-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62887", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "N/A", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1669-2012", "product_description": "METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, This cup delivers 10 mL, Rx Only, Manufactured by VistaPharm, Inc., Largo FL33771", "product_quantity": "73,800 cups", "reason_for_recall": "Labeling: Correct Labeled Product Miscart/Mispack: The shipper label displayed \"5 mL x 50,\" instead of \"10 mL x 50,\"", "recall_initiation_date": "20110119", "center_classification_date": "20120829", "termination_date": "20120830", "report_date": "20120905", "code_info": "195900  exp. 01/12."}, {"country": "United States", "city": "Shenandoah", "address_1": "604 W Thomas Ave", "reason_for_recall": "Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.", "address_2": "", "product_quantity": "1,913,236 tablets", "code_info": "HD17811", "center_classification_date": "20120622", "distribution_pattern": "Nationwide", "state": "IA", "product_description": "Thyro-Tab.075 mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, Iowa 51601.", "report_date": "20120704", "classification": "Class II", "openfda": {}, "recalling_firm": "Lloyd Inc", "recall_number": "D-1395-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "61252", "termination_date": "20130730", "more_code_info": "", "recall_initiation_date": "20120224", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0391580", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LISSAMINE GREEN SOLUTION 1% OPHTHALMIC\t10 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1564-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Huntsville", "address_1": "120 Vintage Dr NE", "reason_for_recall": "Impurities/Degradation Products: High Out of Specification results for a known impurity resulted at the 12-month room temperature time point.", "address_2": "", "product_quantity": "73,746 bottles", "code_info": "Lot #s: L030F11A, L054F11A, Exp 05/13; L095E10A, Exp 06/13; L079J10A, L085K11A, L086K11A, L087G10A, L087K11A, L088K11A, Exp 10/13; L094L10A, Exp 12/13; and L100L10B, Exp 01/14", "center_classification_date": "20120713", "distribution_pattern": "Nationwide", "state": "AL", "product_description": "HYDROXYZINE HYDROCHLORIDE ORAL SOLUTION, USP, 10 mg/5 mL, 1 PINT (473 mL) bottle, Rx only, Mfg. for:  QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-1310-58, UPC 3 0603-1310-58 4.", "report_date": "20120725", "classification": "Class III", "openfda": {}, "recalling_firm": "Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals", "recall_number": "D-1417-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62495", "termination_date": "20131209", "more_code_info": "", "recall_initiation_date": "20120706", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020983"], "brand_name": ["VENTOLIN"], "generic_name": ["ALBUTEROL SULFATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0682"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE"], "rxcui": ["801092", "801095", "859088", "2123076"], "spl_id": ["cce067df-7227-44ec-9bad-494bce12db01"], "spl_set_id": ["d92c5d6b-ff10-4087-36a2-1cfc464cb967"], "package_ndc": ["0173-0682-20", "0173-0682-24"], "is_original_packager": [true], "unii": ["021SEF3731"]}, "product_type": "Drugs", "event_id": "62799", "recalling_firm": "GlaxoSmithKline Inc", "address_1": "1011 North Arendell Ave", "address_2": "P.O. Box 1217", "postal_code": "27597-1217", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1666-2012", "product_description": "Ventolin HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation, 200 Metered Inhalations,  FOR ORAL INHALATION ONLY - For use with Ventolin HFA actuator only.  Net. wt. 18 g Rx only,  GlaxoSmithKline, Reasearch Triangle Park, NC 27709 NDC 0173-0682-20", "product_quantity": "1,412,566 inhalers", "reason_for_recall": "Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification.", "recall_initiation_date": "20120726", "center_classification_date": "20120828", "termination_date": "20140904", "report_date": "20120905", "code_info": "Lot 1ZP7355 Exp. 01/13, 1ZP7749 Exp. 01/13, 1ZP8141 Exp. 01/13, 1ZP8147 Exp. 01/13, 1ZP7729 Exp. 01/13, 1ZP0414 Exp. 03/13, 1ZP0464 Exp. 03/13, 1ZP0570 Exp. 03/13, 1ZP0576 Exp. 03/13, 1ZP0919 Exp. 03/13, 2ZP4959 Exp. 04/13, 2ZP4966 Exp. 04/13"}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "61818", "recalling_firm": "Morton Salt Co.", "address_1": "123 N Wacker Dr", "address_2": "N/A", "postal_code": "60606-1743", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide & PR & Ireland.", "recall_number": "D-1656-2012", "product_description": "Morton, Sodium Chloride, USP, Granular, packaged in kraft paper bags, fiber drums, and semi-bulk bags.  Product is shipped in 80 lb bags, 350 lb drums & 2000 lb semi-bulk sacks.  Manufactured by Morton Salt, Inc., Chicago, Illinois 60606-1743.", "product_quantity": "531,950 lbs", "reason_for_recall": "Impurities/Degradation Products: The product was found to contain a slightly out of specification level of bromides, exceeding the bromides limit for USP Sodium Chloride.", "recall_initiation_date": "20120508", "center_classification_date": "20120820", "termination_date": "20130301", "report_date": "20120829", "code_info": "Lot #: OCT251BC01, NOV041BA01 & NOV071BA01."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "529 units", "code_info": "Rx #'s: 0358246, 0364805,  0368284,  0378756,  0380820,  0387648,  0388175,  0388294,  0388761,  0391370,  0393218,  0393296,  0394349,  0394946,  0395082,  0395861,  0396187,  0398267,  0401319,  0404291,  0405612,  0388186,  0399034,  0386335,  0400431,  0407531,  0358246,  0378756,  0388743,  0400047,  0404363,  0388082,  0409372,  0348455,  0350663,  0353518,  0355129,  0355693,  0356375,  0357470,  0357616,  0358082,  0358244,  0358434,  0359158,  0363285,  0365259,  0367960,  0369601,  0370844,  0370856,  0371600,  0372364,  0373144,  0373375,  0373510,  0374111,  0374998,  0375459,  0375602,  0376024,  0376332,  0376872,  0377260,  0377875,  0377985,  0379138,  0379565,  0381219,  0383350,  0383828,  0383945,  0385030,  0386074,  0386125,  0386686,  0386742,  0387013,  0387677,  0387846,  0387958,  0388044,  0388436,  0388779,  0388809,  0389393,  0389418,  0389598,  0390069,  0390100,  0390105,  0390505,  0390514,  0390727,  0390999,  0391218,  0391382,  0391595,  0391844,  0391948,  0391988,  0392128,  0392227,  0392536,  0392693,  0392724,  0393539,  0393726,  0393837,  0393890,  0394052,  0394339,  0394442,  0394610,  0394740,  0394779,  0394933,  0395044,  0395610,  0396031,  0396423,  0396428,  0396488,  0396514,  0396850,  0396858,  0396885,  0397148,  0397215,  0397247,  0397393,  0397721,  0397747,  0398357,  0398790,  0398832, 0399045,  0399061,  0399186,  0399368,  0399512,  0399565,  0399867,  0400110,  0400648,  0400692,  0401141,  0401171,  0401436,  0401685,  0401963,  0402524,  0402833,  0402836,  0403131,  0403599,  0403651,  0403776, 0404125, 0404206,0404594,0405337, 0405746, 0406186, 0406350, 0406503, 0406533, 0406608, 0406961, 0407011, 0407522, 0407608, 0408149, 0408243, 0408471, 0408475, 0408733, 0408803, 0408948, 0409227, 0409652, 0408211, 0370597, 0372090, 0372291, 0377260, 0383350, 0384600, 0386742, 0387759, 0394740, 0395554, 0398507, 0399696, 0400665, 0407851, 0384600, 0390561, 0390730, 0391280, 0404039, 0398586, 0387759, 0363140, 0373946, 0379198, 0381414, 0388131, 0390621, 0391087, 0396493, 0402322, 0406179, 0406683, 0407311, 0407850, 0408048, 0392605, 0378371, 0388907, 0391868, 0390192, 0396500, 0352172, 0357035, 0358183, 0358360, 0360788, 0366242, 0366923, 0368523, 0369902, 0374538, 0375333, 0375959, 0377935, 0378040, 0378351, 0379207, 0381237, 0382171, 0385235, 0386937, 0387960, 0388158, 0388210, 0388404, 0388444, 0388445, 0388596, 0388605, 0389108, 0389341, 0389709, 0390347, 0390351, 0390846, 0391197, 0391199, 0391635, 0391700, 0391753, 0392003, 0392022, 0392047, 0392213, 0392423, 0392641, 0392690, 0393922, 0394131, 0394193, 0394388, 0394635, 0394718, 0394798, 0395372, 0395626, 0395876, 0396249, 0396718, 0397811, 0398107, 0398194, 0398343, 0398844, 0398887, 0398982, 0399110, 0399320, 0399528, 0399765, 0400046, 0400096, 0400297, 0400421, 0400424, 0400598, 0400913, 0401400, 0401500, 0401680, 0401934, 0402088, 0402325, 0402328, 0402586, 0402967, 0403274, 0403345, 0403607, 0404401, 0405474,0405498, 0405724, 0406291, 0406457, 0406542, 0407511, 0408231, 0409030, 0409062, 0409526, 0409607, 0409759, 0410307, 0393753, 0397762, 0403540, 0374221, 0382214, 0395621, 0397852, 0402288, 0406445, 0399687, 0374221, 0366701, 0351976, 0354103, 0384453, 0390423, 0391629, 0393615, 0396582, 0397827, 0398720, 0399013, 0403466, 0406583, 0409862, 0397208, 0361392, 0379145, 0380920, 0387005, 0400616, 0404590, 0404931, 0396725, 0392873, 0357803, 0363807, 0365784, 0370228, 0372609, 0376996, 0377620, 0378319, 0380457, 0381999, 0382394, 0382527, 0382743, 0382990, 0386135, 0386929, 0387451, 0387674, 0389081, 0389143, 0389875, 0390000, 0390409, 0391030, 0391711, 0392245, 0392563, 0392705, 0392767, 0393396, 0393794, 0394466, 0395061, 0396510, 0397503, 0397715, 0397737, 0397916, 0397953, 0398923, 0399635, 0399757, 0399812, 0400282, 0400880, 0402467, 0403426, 0403519, 0403728, 0403832, 0404015, 0404522, 0405565, 0405585, 0406128, 0406628, 0407265, 0407357, 0407736, 0407839, 0408178, 0408378, 0409610, 0409944, 0388717, 0394665, 0367237, 0368886, 0401105, 0395886, 0397863, 0388295, 0387427, 0388295, 0397030", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ALPROSTADIL  10MCG/ML INJECTABLE 10 ML, 20 ML, 3 ML, 30 ML, 5 ML, 6 ML; ALPROSTADIL  15MCG/ML INJECTABLE 5 ML; ALPROSTADIL  20MCG/ML INJECTABLE 10 ML, 10 MLS, 20 ML, 3 ML, 30 ML, 4 ML, 40 ML, 5 ML, 6 ML; ALPROSTADIL  24MCG/ML INJECTABLE 6 ML; ALPROSTADIL  25MCG/ML INJECTABLE 10 ML; ALPROSTADIL  30MCG/ML INJECTABLE 10 ML; ALPROSTADIL  35MCG/ML INJECTABLE 10 ML; ALPROSTADIL  40MCG/ML INJECTABLE 10 ML, 10 ML, 10 VIAL, 15 ML, 2 ML, 20 ML, 3 ML, 30 ML, 40 ML, 5 ML, 50 ML, 6 ML; ALPROSTADIL  50MCG/ML INJECTABLE\t10 ML, 2 ML, 20 ML, 5 ML; ALPROSTADIL  60MCG/ML INJECTABLE\t20 ML; ALPROSTADIL (M) 500MCG/ML INJECTABLE 10 ML; ALPROSTADIL 100MCG/ML INJECTABLE 5 ML; ALPROSTADIL, STERILE 1,000MCG/ML GEL 10 ML, 12 ML, 20 ML, 3 ML, 30 ML, 6 ML; ALPROSTADIL/PAPAVERINE  10MCG/9MG/ML INJECTABLE; ALPROSTADIL/PHENT 10MCG/0.5MG/ML INJECTABLE 10 ML, 5 ML; ALPROSTADIL/PHENT 17MCG/0.5MG/ML INJECTABLE 10 ML; ALPROSTADIL/PHENTOLAMINE 40MCG/2MG/ML INJECTABLE 10 ML (50 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1452-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "434 units", "code_info": "Rx #'s:   0367755          0397544    0397544      0394203    0394203    0353087    0394203        0394203      0391064    0396617    0396618    0397379    0397665    0389435    0397604    0398197    0400182      0406428    0406441    0407299    0408671    0392392    0392866    0395109          0397604      0398121    0406401    0406428    0391064    0392866    0391064    0392394    0397379      0397401    0396330    0409785    0392392    0409993    0389435    0392394    0394007    0398254      0398371    0398197    0397564    0392532    0397401    0406158    0408033    0388839    0398070    0390935    0391064    0392392        0400496    0392394    0391064      0401695    0394973      0409350    0389048      0392392    0395192    0395322    0396495    0397014    0397235    0397286    0398200    0410339    0408395    0392392    0396495    0402468    0405322    0400938      0398892    0404270    0391064    0403246    0407249    0406513    0406511    0388935    0398116    0398651    0400184    0404681    0396015    0406879    0408191    0407760    0398152    0392177      0396015    0396776        0397935    0398690    0388570    0404681    0396331    0386589    0392123    0400499    0406879    0397574    0387654      0387657      0392123    0389739    0392177    0388570      0389520    0405648    0395417    0408169    0388570    0386589    0398344    0398897    0399058    0404400    0406370    0406409    0387654    0387657    0388315        0395460    0397237    0398140    0401098      0388570      0392120    0405324    0405865    0398386    0396384    0398522    0407403    0395328    0407403    0401899    0395328    0396384          0400983    0385425    0385425          0408240    0398953    0398955    0399006    0397926        0397701      0398953    0406581        0397701    0398955    0397926                                                                      0403958    0395327    0399741    0399741    0398231    0398955    0395209    0395209        0395209    0398953    0398955    0408343    0408356    0408359    0408361    0398953              0398955      0399741    0398953    0395327    0403237    0398228    0403237    0403822    0403955    0403237    0404870    0352507    0354115        0355699    0357889    0359365      0360370    0364979    0369341      0371280    0372079    0373472    0374032    0374306    0376181            0378274    0380074    0381850    0385344    0385547    0386110      0386788      0387127    0387422    0387464    0387859    0388713    0389087    0389291    0389369    0392010    0392179    0393703      0393791    0394288      0395465    0395688      0396321    0397535    0399096    0400643      0400805    0400842      0400849    0401048    0401101        0401253    0402339    0403298      0405184    0405477    0405647    0406833    0406870    0409282    0403815    0384363    0398902    0354644    0359373    0359556      0361151    0365492        0374306    0384183    0385520    0385547    0387466      0389030    0389369    0389936      0390088        0390875    0391203        0391252    0391254    0391255    0391808    0392555    0395499    0396125    0397244      0401048    0401553    0402814    0403285    0404205    0404211    0404219    0406766    0358069    0401639    0363813    0386485      0387583    0390418      0390538      0391203    0393542    0394622    0401048    0408256    0348902    0363945    0365492    0366731    0382057    0392179      0396006    0399798      0407366    0365954    0404604    0354990    0363945      0385338      0395499    0400889    0379753          0389066    0393699      0365954    0391256    0380645      0353540    0395979      0409426", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LIDOCAINE HCL  (STERILE) 4% JELLY\t120 ML  \t  \t  \t  \t  \t30 ML;  \t  LIDOCAINE HCL  4% SOLUTION\t200 ML  \t300 ML  \t500 ML  \t  \t  \t  \t600 ML;  \t  LIDOCAINE HCL 1% INJECTABLE\t100 ML  \t  \t  \t  \t  \t1000 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t1200 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t1250 ML  \t  \t150 ML  \t  \t  \t  \t  \t1500 ML  \t  \t180 ML  \t  \t20 ML  \t200 ML  \t  \t  \t  \t  \t2000 ML  \t240 ML  \t250 ML  \t  \t  \t  \t2500 ML  \t  \t300 ML  \t  \t  \t  \t  \t  \t350 ML  \t360 ML  \t  \t400 ML  \t480 ML  \t  \t50 ML  \t500 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t60 ML  \t600 ML  \t  \t  \t  \t720 ML  \t  \t750 ML  \t7500 ML  \t90 ML;  LIDOCAINE HCL 10% INJECTABLE\t1000 ML;  LIDOCAINE HCL IN BSS - P.F. OPHTHALMIC 1% INJECTABLE\t30 ML;  LIDOCAINE HCL W/EPI (25X30ML) MDV *** 1%-1:100000 INJECTABLE\t150 MLS  \t180 MLS  \t50 VIALS;  LIDOCAINE HCL, AQUEOUS  2% INJECTABLE\t100 ML  \t  \t  \t  \t1000 ML  \t  \t  \t120 ML  \t1200 GM  \t1200 ML  \t  \t  \t  \t  \t  \t  \t  \t150 ML  \t  \t1500 ML  \t20 ML  \t200 ML  \t  \t2000 ML  \t240 ML  \t250 ML  \t  \t  \t  \t  \t2500 ML  \t  \t300 ML  \t  \t  \t  \t40 ML  \t  \t450 ML  \t480 ML  \t  \t50 ML  \t  \t  \t  \t  \t500 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t600 ML  \t  \t  \t  \t  \t80 ML;  LIDOCAINE HCL, AQUEOUS PF 2% INJECTABLE\t1200 ML  \t1500 ML  \t1600 ML  \t200 ML  \t250 ML  \t50 ML  \t500 ML  \t600 ML  \t  \t  \t  \t900 ML;  LIDOCAINE HCL, AQUEOUS, BUFFERED, P.F. 2% INJECTABLE\t1000 ML  \t500 ML;  \t  \t  \t  LIDOCAINE HCL, P.F. 0.5% INJECTABLE\t1000 ML;  LIDOCAINE HCL, P.F. 1% INJECTABLE\t100 ML  \t  \t  \t12 ML  \t  \t  \t120 ML  \t  \t  \t  \t  \t  \t125 ML  \t150 ML  \t24 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t240 ML  \t2500 ML  \t2670 ML  \t30 ML  \t300 ML  \t  \t40 ML  \t48 ML  \t  \t  \t50 ML  \t  \t  \t6 ML  \t  \t  \t  \t60 ML  \t  \t  \t  \t  \t  \t  \t  \t720 ML  \t80 ML  \t900 ML;  LIDOCAINE HCL, P.F. 4% INJECTABLE\t100 ML  \t1000 ML  \t125 ML  \t225 ML  \t240 ML  \t75 ML  LIDOCAINE HCL/METHYLCELLULOSE 1%/2% JELLY\t2 ML;  LIDOCAINE HCL/METHYLCELLULOSE 2%/2% JELLY\t1000 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t1000 MLS  \t12000 ML  \t200 ML  \t2000 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2000 MLS  \t  \t3000 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t4000 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t500 ML  \t  \t5000 ML  \t  \t  \t  \t  \t  \t  \t6000 ML  \t  \t  \t  \t  \t  \t  \t750 ML;  LIDOCAINE HCL/METHYLCELLULOSE 4%/2% JELLY\t1000 ML;  LIDOCAINE HCL/METHYLCELLULOSE 5%/2% JELLY\t1000 ML;  \t  LIDOCAINE HCL/METHYLCELLULOSE 8%/2% JELLY\t1000 ML  (111 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1558-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s: 0391287, 0398843, 0398843", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "AFLIBERCEPT, SDPF - (0.05ML SYRINGE, 31G, 5/16\") 40MG/ML INJECTABLE 0.35 ML, 0.95 ML, 1.25 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1451-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0387447", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CYCLOPENT/PHENYLEPH/TROPICAMIDE/PROPARACAINE 2%/2.5%/1%/0.5% OPHTHALMIC 5 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1492-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "61934", "recalling_firm": "Ranbaxy Inc.", "address_1": "600 College Rd E Ste 2100", "address_2": "N/A", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1405-2012", "product_description": "Balnetar Therapeutic Tar Bath, Coal Tar USP 2.5% (from Coal Tar USP Solution, 7%), 7.5 oz bottle, Distributed by Ranbaxy, Jacksonville, FL 32257, NDC 10631-106-08", "product_quantity": "2544 bottles", "reason_for_recall": "Subpotent (Single Ingredient Drug): out-of-specification result for coal tar content assay.", "recall_initiation_date": "20120316", "center_classification_date": "20120703", "termination_date": "20130226", "report_date": "20120711", "code_info": "Lot #: RB81031, Exp 01/13"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "17 units", "code_info": "Rx #'s:  0391527    0391528    0393746      0391527    0391528    0393746      0403451    0404796    0397463    0402780      0402781    0402208    0396691    0402780", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MANNITOL 20% INJECTABLE\t1250 ML  \t  \t250 ML  \t  \t2500 ML  \t  \t400 ML;  \t  MANNITOL 25% INJECTABLE\t1200 ML  \t  \t300 ML  \t  \t  \t  \t350 ML  \t400 ML  \t600 ML  (9 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1569-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "17 units", "code_info": "Rx #'s:C0397709  C0403979  C0387544  C0387581  C0387806  C0388157  C0395001  C0397028  C0397915  C0400555  C0400709  C0404008  C0405234  C0390252  C0391731  C0393592  C0406126", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TESTOSTERONE CYP/ESTRADIOL CYP 50MG/2MG/ML INJECTABLE\t5 ML;  TESTOSTERONE CYPIONATE 50MG/ML INJECTABLE\t12 ML  \t2.5 ML  (4 DIFFERENT PRODUCTS)\t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t5 ML;  \t  \t  TESTOSTERONE PROPIONATE 200MG/ML INJECTABLE\t10 ML", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1621-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:   0374732    0374732", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "STRONTIUM 1 MG/ML INJECTABLE\t30 ML  \t60 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1619-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "87 units", "code_info": "Rx #'s:   0387290    0387290    0400922    0405419    0362272        0362272      0392196    0392211    0389062    0402046    0366190        0376388    0377225    0363673    0355420    0394877    0359658    0361833    0376569    0390305    0394394    0394710    0397895    0399493    0402872    0403787    0394877    0365100    0390365    0391344    0391346    0391866    0405531    0355420      0399719      0365828        0394562    0380506    0406925    0398935    0387737    0387737    0401220    0404375    0387737    0395444    0398847    0360739    0365769        0365769    0404497    0407975    0408999    0351511    0398847    0361324    0403770    0410188    0405655    0365764    0403770    0406991    0365769    0403770    0407885    0403574    0403577    0404165    0403579    0392063    0400699    0397870    0397870    0402420    0402420    0406941", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TRIAMCINOLONE ACETONIDE  4MG/ML (0.4MG/0.1ML) INJECTABLE\t10 ML  \t5 ML  TRIAMCINOLONE ACETONIDE (T), STSL (0.025ML SYRINGE, 30G, 1/2\") 40MG/ML (4MG/0.1M\t0.075 SYR  \t0.1 SYR  TRIAMCINOLONE ACETONIDE 0.25ML SYRINGE (T) 40MG/ML (4MG/0.1ML) OPHTHALMIC\t0.25 ML  \t  \t  \t0.5 ML  \t  TRIAMCINOLONE ACETONIDE 20MG/ML INJECTABLE\t1 ML  TRIAMCINOLONE ACETONIDE 80MG/ML INJECTABLE\t100 ML  TRIAMCINOLONE ACETONIDE IN VITREOUS VEHICLE, P.F. 10MG/ML (1MG/0.1ML) OPHTHALMIC\t0.1 ML  \t  \t50 ML  \t  \t  TRIAMCINOLONE ACETONIDE IN VITREOUS VEHICLE, P.F. 20MG/ML (2MG/0.1ML) OPHTHALMIC\t0.1 ML  \t  \t0.2 ML  TRIAMCINOLONE ACETONIDE IN VITREOUS VEHICLE, P.F. 40MG/ML (4MG/0.1ML) OPHTHALMIC\t0.05 ML  \t  \t0.1 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t0.15 ML  \t0.2 ML  \t  \t  \t  \t  \t  \t0.25 ML  \t  \t  \t  \t0.5 ML  \t  \t  \t  \t0.6 ML  \t0.75 ML  \t0.8 ML  \t0.9 ML  \t1 ML  \t  \t  \t1.2 ML  \t  \t1.25 ML  \t10 ML  \t  \t  \t  \t14 ML  \t2 ML  \t  \t  \t2.5 ML  \t  \t3 ML  \t  \t30 ML  \t360 ML  \t4 ML  \t  \t5 ML  \t6 ML  \t8 ML  TRIAMCINOLONE ACETONIDE IN VITREOUS VEHICLE, P.F. 80MG/ML (8MG/0.1ML) OPHTHALMIC\t0.25 ML  \t0.3 ML  \t0.5 ML  \t0.75 ML  \t2 ML  TRIAMCINOLONE ACETONIDE P.F. (OPHTHALMIC) 40MG/ML (4MG/0.1ML) OPHTHALMIC\t1 ML  \t10 ML  TRIAMCINOLONE ACETONIDE, P.F. 80MG/ML INJECTABLE\t150 ML  \t75 ML  TRIAMCINOLONE DIACETATE 40MG/ML INJECTABLE\t3 ML  \t4 ML  TRIAMCINOLONE DIACETATE, PRESERVATIVE FREE 40MG/ML INJECTABLE\t360 ML  (48 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1628-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "33 units", "code_info": "Rx #'s:  0397555    0397557    0382534        0400837        0407829    0390562          0390562        0395167    0397757    0396775    0394599    0390562          0396775    0390562    0390562    0396775    0389984    0387701    0389984", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "EPINEPHRINE **(25X1ML AMPULS) 1:1000 1MG/ML INJECTABLE 25 ML;  EPINEPHRINE HCL SOLUTION 1% OPHTHALMIC 10 ML, 20 ML; EPIINEPHRINE P.F. (SULFITE-FREE) 1:1,000 (1MG/ML) INJECTABLE 1 ML, 2 ML, 20 ML, 25 ML, 3 ML, 30 ML, 4 ML, 5 ML, 50 ML; EPINEPHRINE PF IN BSS, OPHTHALMIC (CONTAINS SULFITES) 1:1000 (1MG/ML) INJECTABLE\t15 ML, 16 ML, 30 ML (15 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1514-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62392", "recalling_firm": "GlaxoSmithKline Inc", "address_1": "1011 North Arendell Ave", "address_2": "P.O. Box 1217", "postal_code": "27597-1217", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1412-2012", "product_description": "Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18", "product_quantity": "14,465 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.", "recall_initiation_date": "20120604", "center_classification_date": "20120712", "termination_date": "20140904", "report_date": "20120718", "code_info": "Lot #0ZP5128 exp; 8/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Wayne", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62651", "recalling_firm": "Bayer HealthCare Pharmaceuticals Inc.", "address_1": "6 W Belt Plz", "address_2": "N/A", "postal_code": "07470", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Kansas and California.", "recall_number": "D-1433-2012", "product_description": "Estradiol Hemihydrate M20 EP/USP Powder, packaged in a) 1.5 kg and b) 2.5 kg fiber drums, Rx only, Art. No. 165811, Bayer Pharma AG, D-13342 Berlin.", "product_quantity": "112.295 kg", "reason_for_recall": "Cross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product.", "recall_initiation_date": "20120508", "center_classification_date": "20120731", "termination_date": "20121218", "report_date": "20120808", "code_info": "Lot Number: 81202450, Exp 06/15/16"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0410015", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ENGERIX-B, SDV** 20MCG/ML INJECTABLE 1 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1513-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:   0374326            0374326", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MOLYBDENUM 250MCG/ML INJECTABLE\t30 ML  \t  \t  \t  \t  \t60 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1584-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #:   0390500", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "NADH-FFC 10 MG/CC INJECTABLE\t10 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1587-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Gainesville", "address_1": "2481 Hilton Dr", "reason_for_recall": "Labeling: Label Mix-Up; Some bottles of Tizanidine 4mg Tablets, had the incorrect manufacturer (Actavis) printed on the label.", "address_2": "", "product_quantity": "51 Bottles", "code_info": "Lot #: 28JN1272, Exp 02/15", "center_classification_date": "20120726", "distribution_pattern": "Nationwide", "state": "GA", "product_description": "Tizanidine (Generic for: Zanaflex), 4 mg, 90 Tablets per Bottle, Rx only, , Mfg By: Dr Reddys Labs Ltd., Bachepally, IN 500 - 090, Packaged and distributed by STAT Rx USA, Gainesville, GA, NDC 16590-221-90.", "report_date": "20120801", "classification": "Class III", "openfda": {}, "recalling_firm": "Stat Rx USA", "recall_number": "D-1427-2012", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "62639", "termination_date": "20130131", "more_code_info": "", "recall_initiation_date": "20120723", "postal_code": "30501-6213", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:   0402993    0394666", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PAPAVERINE HCL **(10ML VIAL) 30MG/ML INJECTABLE\t10 ML  \t100 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1593-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "32 units", "code_info": "Rx #'s:  0398523,  0404345,  0404347,  0404348,  0404349,  0404351,  0406460,  0384921,  0395199,  0399779,  0379708,  0395199,  0389329,  0409506,  0378436", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ATROPINE SULFATE  0.4MG/ML INJECTABLE 12 ML, 2 ML, 20 ML, 24 ML, 25 ML, 3 ML; ATROPINE/EPINEPHRINE/ BSS 0.02MG/0.1MG/ML INJECTABLE 10 ML, 5 ML (8 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1458-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62407", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1436-2012", "product_description": "Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA  92880; Distributed by: Watson Pharma, Inc., Corona, CA  92880.", "product_quantity": "18,938 cartons", "reason_for_recall": "Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.", "recall_initiation_date": "20120605", "center_classification_date": "20120801", "termination_date": "20130318", "report_date": "20120808", "code_info": "Lot #s: 412572A, 412572B, Exp 11/12"}, {"country": "United States", "city": "Sanford", "address_1": "2650 S Mellonville Ave", "reason_for_recall": "Subpotent; fluocinolone acetonide", "address_2": "", "product_quantity": "161,064 bottles", "code_info": "Lot Numbers:   -Scalp Oil: H100084 (exp 08/12), H100086 (08/12), J100093 (exp 08/12), J100094 (exp 09/12), J100097 (exp 09/12), K100101 (exp 09/12), K100103 (exp 10/12), K100104 (exp 10/12), K100108 (exp 10/12), K100112 (exp 10/12), L100860 (exp 11/12), L100890 (exp 11/12), L100910 (exp 11/12).", "center_classification_date": "20120814", "distribution_pattern": "Nationwide", "state": "FL", "product_description": "Derma-Smoothe/FS (Fluocinolone Acetonide) 0.01% Topical Oil (Scalp Oil), 4 fl oz (118.28mL) bottle, Rx only, FOR TOPICAL USE ONLY NOT, Manufactured and Distributed by: Hill Dermaceuticals, Inc. SANFORD, FLORIDA ---  NDC 28105-149-04", "report_date": "20120822", "classification": "Class III", "openfda": {}, "recalling_firm": "Hill Dermaceuticals, Inc.", "recall_number": "D-1646-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "62607", "termination_date": "20150210", "more_code_info": "", "recall_initiation_date": "20120508", "postal_code": "32773-9311", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #'s:   0377832      0377832", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "IOPAMIDOL 41% INJECTABLE\t198 ML  \t  \t99 ML  \t50 ML  \t600 ML  \t72 ML;  \t  \t  \t  IOHEXOL,  4ML VIAL 240MG IODINE/ML INJECTABLE\t200 ML;  IOHEXOL, 3ML VIAL 300MG IODINE/ML INJECTABLE\t180 ML  \t600 ML  \t  \t90 ML  \t  \t  \t  \t  \t900 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1549-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #:    0395658", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "FORSKOLIN/PHENTOLAMINE 200MCG / 2MG INJECTABLE 5 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1524-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "208 units", "code_info": "Rx #'s:  0391301    0391927    0397282      0399470    0391327    0392711    0394996    0401004    0395010    0388696    0389279    0401772    0402650    0404045    0404779    0406029    0408374    0403432    0392999    0395958    0396932    0398177    0405143    0405968    0407753    0365101      0365105      0365106      0365108    0371252          0371257          0371265          0371268          0371270          0382419    0391063    0391522    0393199    0403490    0406625    0406627    0406630    0409573    0409579    0409599    0403432    0387860    0388243    0389493    0390022    0390530    0391010    0391294    0391645    0392576    0392665    0392688    0392894    0393040    0393092    0393216    0393335    0393561    0393731    0395678    0396033    0397292    0398299    0398311    0399018    0400098    0400351    0400429    0400575    0400578    0400982    0401079    0401385    0401646    0401948    0402176    0402516    0402557    0402580    0402987    0403982    0405357    0405430    0405445    0407384    0407808    0407965    0408244    0408382    0408419    0408726    0408792    0409348    0381200        0361853      0392328    0394367    0399209      0390487    0391522        0397635          0381200    0380708              0352927    0361537    0367181    0371957    0373468    0375263    0376692    0378305    0381683      0382865      0384081      0385565      0387059        0387814      0388443    0388942    0388944      0389430    0391105    0397310      0400625    0402660      0403566    0407971    0407993    0388536    0388536      0368410    0388443    0396037    0397310    0400776    0404858    0405790    0404952    0369001                  0367492    0400900    0371731    0371731    0371731    0400549    0406613    0392439    0392439    0401628      0392136", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "METHYLCOBALAMIN  1,000MCG/ML INJECTABLE\t10 ML  \t  \t  \t  \t  \t12 ML  \t  \t  \t  \t15 ML  \t150 ML  \t2 ML  \t  \t  \t  \t  \t  \t  \t26 MLS  \t3 ML  \t  \t  \t  \t  \t  \t  \t30 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t30 MLS  \t4 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t40 ML  \t  \t  \t5 ML  \t  \t  \t  \t  \t  \t6 ML  \t60 ML  \t  \t  \t  \t  \t  \t  \t80 ML  \t90 ML;  \t  \t  \t  \t  \t  METHYLCOBALAMIN ( DR HALL KIT) 1,000MCG/ML INJECTABLE\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t1 ML  \t10 ML  \t  \t30 ML;  \t  \t  \t  \t  \t  \t  METHYLCOBALAMIN ( DR HALL KIT) PRESERVATIVE FREE 1,000MCG/ML INJECTABLE\t1 KIT;  METHYLCOBALAMIN (PRESERV FREE) 1,000MCG/ML INJECTABLE\t4 ML  \t  \t  \t  \t  \t  \t  \t  \t8 ML;  \t  METHYLCOBALAMIN (PRESERV FREE) 25,000MCG/ML INJECTABLE\t1.5 ML  \t3 ML  \t3.5 ML  \t60 ML;  METHYLCOBALAMIN (PRESERVATIVE  FREE) 25MG/ML INJECTABLE\t30 ML  \t4 ML  \t8 ML;  \t  \t  METHYLCOBALAMIN 5,000MCG/ML INJECTABLE\t6 ML  (31 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1573-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "64 units", "code_info": "Rx #'s:  T0372867  T0387431  T0388104  T0389467    T0389651  T0389841  T0391671  T0394240    T0395182  T0395583  T0396607  T0397069  T0397176  T0398192  T0399822  T0399900  T0400079  T0400081  T0400293  T0400444  T0400658  T0400794  T0400806  T0400871  T0401635  T0401644  T0401957  T0402166  T0402388  T0402390  T0402553  T0402656  T0402943  T0403559  T0405372  T0405460  T0406116  T0406555  T0406565  T0406984  T0407064  T0407383  T0407394  T0407440  T0407793  T0408122  T0408306  T0408399  T0408744  T0409050  T0409093  T0409107  T0409169  T0409178  T0396714  T0394672    T0395926  T0394672  T0394672  T0398564  T0394672", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TROCAR KIT, STERILE DISPOSABLE**  DEVICE\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t1 PELLET  \t2 KIT  \t  \t  \t3 KIT  \t4 KIT  \t5 KITS  \t6 KIT  (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1631-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Roswell", "address_1": "1400 Holcomb Bridge Rd", "reason_for_recall": "Microbial Contamination of Non-Sterile Products; The affected lots were found to be contaminated with bacterium, Burkholderia cepacia complex.", "address_2": "", "product_quantity": "5268 Cassettes", "code_info": "SKU #12977-00 (Cassette - 1 Liter), Lot #: SA1229ANB; b) SKU #12979-00 (E-Cassette - 1.2 Liters), Lot #: SA1229ANA, Exp 08/13", "center_classification_date": "20120712", "distribution_pattern": "Nationwide and Canada", "state": "GA", "product_description": "Kleenex Luxury Foam Hand Sanitizer, (Benzalkonium Chloride 0.1%), in a) 1 Liter (33.8 fl oz.), b) 1.2 Liters (40.5 fl oz.) Cassettes, Distributed by Kimberly Clark, LLC, Roswell, GA 30076", "report_date": "20120718", "classification": "Class II", "openfda": {}, "recalling_firm": "Kimberly-Clark Corporation", "recall_number": "D-1414-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "62418", "termination_date": "20130409", "more_code_info": "", "recall_initiation_date": "20120614", "postal_code": "30076", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "197 units", "code_info": "Rx #'s:  0400830    0400830    0403915    0369559    0382655                                0355231    0363469    0364194    0364586    0365232    0368229      0368502            0368575    0379338    0379547        0383465    0387854      0389349      0390953      0391076      0392073    0394447    0394682    0394934    0395429    0395951      0396729    0397109    0397667    0404203    0404799    0405703    0406025    0408991    0359179    0359179    0348862    0356877    0360153    0363384    0363885    0364194    0364239    0366032      0366271    0368245        0368882    0376169    0380550      0382237    0384296    0385288    0387375    0387380        0387486    0388896    0389392    0390771    0392073      0394447    0399970    0399989    0403141    0403755      0405329    0365743    0384729    0389303      0396299      0353130    0355933    0356625    0362693    0363384    0363667    0368575      0368882      0371797      0375692    0380344    0383379    0387330      0387486    0388896    0392336    0392543    0395951    0396870    0402552    0409017    0375411    0395390    0358612    0362693    0366271    0371046    0375511    0375514    0375515    0375518    0375519    0375692    0384296      0387483    0392020    0392336    0408625    0376091      0399724    0356877    0405109    0408823    0362693    0371046    0375356        0375503      0375504      0375506      0375507    0375510      0375511    0375514    0375515    0375518    0375519    0392020      0392336    0396870    0398875    0368836    0354413    0398562    0354048    0389058    0389206      0405941    0358048    0387432    0402040    0391715    0391715    0393524    0404316    0391708    0402008      0391708", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CEFTAZIDIME OPHTHALMIC, P.F. 22.5MG/ML (2.25%) OPHTHALMIC 1 ML, 2ML, 2 MLS, 6 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  CEFTAZIDIME, LYOPHILIZED, OPHTHALMIC KIT 2.25% KIT\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t12 KIT  \t16 KIT  \t2 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2 KITS  \t  \t20 KIT  \t  \t  \t  \t3 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t3 KITS  \t  \t4 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t4 KITS  \t  \t4 VIALS  \t5 KIT  \t  \t  \t6 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t6 VIAL  \t8 KIT  \t  CEFTAZIDIME, SDPF - (0.2ML SYRINGE, 30G, 1/2\") 2.25% INJECTABLE\t0.2 ML  \t  \t  \t  \t  \t0.4 ML  \t  \t  \t0.6 ML  \t0.8 ML  \t  \t  \t1.2 ML  \t  \t  \t1.6 ML (25 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1482-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "18 units", "code_info": "Rx #'s:  0387489    0387820    0401069    0393386      0387489    0387489    0374184    0374184            0374184", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "POVIDONE-IODINE OPHTHALMIC 5% SOLUTION\t10 ML  \t  \t125 ML  \t15 ML  \t  \t40 ML  \t50 ML;  POVIDONE-IODINE, BUFFERED IN BSS 4.6% OPHTHALMIC\t100 ML  \t120 ML  \t  \t  \t  \t  \t200 ML  (8 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1604-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s: T0395419  T0393096", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DROPTAINER STERILE PLASTIC (2 X 7ML) 10 BOTTLE 4 PK (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1510-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:  0389887    0399968    0398811", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYDROXOCOBALAMIN**(VIT B-12) 1000MCG/ML INJECTABLE 30 ML Injectable (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1543-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #'s: 0384117, 0407161", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ACYCLOVIR OPHTHALMIC 3% OINTMENT 5 GM; ACYCLOVIR OPHTHALMIC 3% SOLUTION 5 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1450-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "17 units", "code_info": "Rx #'s:  0359944    0359944      0408186", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYALURONIDASE / LIDOCAINE 7.1U/9.5MG/ML INJECTABLE 105 ML,\t210 ML (6 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1535-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0394097", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LIDOCAINE/SODIUM BICARBONATE/HEPARIN  IRRIGATION  10.6MG/16.8MG/2667U/ML SOLUTIO\t90 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1562-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077090"], "brand_name": ["LEFLUNOMIDE"], "generic_name": ["LEFLUNOMIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-2502", "60505-2503"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEFLUNOMIDE"], "rxcui": ["205284", "205285"], "spl_id": ["ebee26d4-bf2a-e0eb-b0f4-e1212d0bed03"], "spl_set_id": ["753453c5-8a7a-878e-3ce7-1d1edce718a9"], "package_ndc": ["60505-2502-1", "60505-2502-2", "60505-2502-3", "60505-2503-1", "60505-2503-2", "60505-2503-3"], "is_original_packager": [true], "nui": ["N0000175713"], "pharm_class_epc": ["Antirheumatic Agent [EPC]"], "unii": ["G162GK9U4W"]}, "product_type": "Drugs", "event_id": "38329", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy", "address_2": "Ste 400", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "Nationwide.", "recall_number": "D-1661-2012", "product_description": "Leflunomide tablets, 10 mg, a) 30-count bottle (NDC 60505-2502-1), b) 1000-count bottle (NDC 60505-2502-3), Rx only, Manufactured for Apotex Corp., Weston, Florida 33326 by Apotex Inc., Toronto, Ontario Canada M9L 1T9", "product_quantity": "3063", "reason_for_recall": "Subpotent (Single Ingredient Drug): Distribution of product that did not meet specifications.", "recall_initiation_date": "20070614", "center_classification_date": "20120827", "termination_date": "20120828", "report_date": "20120905", "code_info": "Lot #: a) GY4197, Exp 11/07; b) GZ1273, Exp 11/07."}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:N0395798  N0397394  N0392201  N0400799  N0403781  N0407180  N0390189", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYDROMORPHONE/CLONIDINE P. F. 120MG/1.3MCG/ML INTRATHECAL 10 ML; HYDROMORPHONE/CLONIDINE P. F. 120MG/1.8MCG/ML INTRATHECAL 10 ML; HYDROMORPHONE/CLONIDINE P. F. 80MG/1.2MCG/ML INTRATHECAL 10 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1542-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "40 units", "code_info": "Rx #'s:   0398633    0374138                0407059      0395611          0366358        0382466      0385492        0405984    0407947    0409833    0369221        0401142    0364989        0385219    0389327    0389381        0395535    0402826    0406693", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CYCLOSPORINE (A) AQUEOUS (HUMAN)  0.5% OPHTHALMIC 10 ML,\t5 ML;  CYCLOSPORINE (A) AQUEOUS PF   (HUMAN)  0.2% OPHTHALMIC 10 ML;  CYCLOSPORINE (A) AQUEOUS PF (HUMAN)  1% OPHTHALMIC 10 ML;  CYCLOSPORINE (A) CORN OIL SOLUTION 2% OPHTHALMIC 15 ML; CYCLOSPORINE (A) OIL SOLUTION 1% OPHTHALMIC 10 ML, 20 ML, 60 ML;  CYCLOSPORINE (A) OIL SOLUTION 2% OPHTHALMIC 10 ML, 15 ML, 20 ML, 30 ML (12 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1494-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076517"], "brand_name": ["CARBOPLATIN"], "generic_name": ["CARBOPLATIN"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-339", "61703-150", "61703-360", "61703-262", "61703-600"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CARBOPLATIN"], "rxcui": ["597195"], "spl_id": ["0ddf4411-7138-412a-908a-fadf22bdfb79", "5aa72c15-8033-4559-b257-373371b18958"], "spl_set_id": ["c3ae9880-44bb-4f4e-93d8-8a5e21708a30", "47677091-fd20-49af-933c-c9dd2be21de9"], "package_ndc": ["61703-339-18", "61703-339-22", "61703-339-50", "61703-339-56", "61703-360-18", "61703-150-05", "61703-262-05", "61703-600-05", "61703-360-50"], "is_original_packager": [true], "nui": ["N0000175413", "N0000175073"], "pharm_class_epc": ["Platinum-based Drug [EPC]"], "unii": ["BG3F62OND5"]}, "product_type": "Drugs", "event_id": "62463", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1648-2012", "product_description": "Carboplatin Injection, 10 mg/mL, a) 5 mL multi-dose vials (NDC 61703-339-18) (NDC 61703-360-18, NOVAPLUS),  b) 45 mL multi-dose vials (NDC 61703-339-50) (NDC 61703-360-50 NOVAPLUS), Rx only, Hospira, Inc., Lake Forest, IL 60045, Product of Australia", "product_quantity": "77,542 vials", "reason_for_recall": "Failed PH specification:  The lots of Carboplatin Injection were manufactured from Carboplatin API lots which trended out of specification low pH.", "recall_initiation_date": "20120702", "center_classification_date": "20120816", "termination_date": "20170724", "report_date": "20120822", "code_info": "5 mL vial - NDC 61703-339-18 (Hospira label), lot number Y031654AB, expiration APR2013; NDC 61703-360-18 (Novoplus label), lot number Y031654AA, expiration APR2013;   45 mL vial - NDC 61703-339-50 (Hospira label), lot numbers Y041711AA, expiration DEC 2012 and Y061711AB, expiration FEB 2013; NDC 61703-360-50 (Novoplus label), lot number Y061711AA, expiration FEB 2013", "more_code_info": ""}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62383", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1399-2012", "product_description": "Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880  NDC #  00591-0369-01.", "product_quantity": "8254 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.", "recall_initiation_date": "20120417", "center_classification_date": "20120629", "termination_date": "20130318", "report_date": "20120711", "code_info": "Lot 108094A"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0400257", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DEXAMETHASONE/BACTERIOSTATIC WATER  IONTOPHORESIS  0.5MG/5ML(0.1MG/ML) INJECTABL 30 ML (1 PRODUCT)    \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t40 ML  DEXAMETHASONE SDPF (0.1ML SYRINGE, 31G, 5/16\" ) 0.4MG/ML INJECTABLE\t0.3 ML  \t0.5 ML  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 10MG/ML (1%) INJECTABLE\t0.05 ML  \t1 ML  \t16 ML  \t  \t  \t  \t  \t2 ML  \t  \t24 ML  \t  \t  \t3 ML  \t  \t  \t32 ML  \t8 ML  \t  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 4MG/ML (0.4%) INJECTABLE\t0.4 ML  \t2 ML  \t3 ML  \t  \t5 ML  \t6 ML  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 80MG/ML (8%) INJECTABLE\t100 ML  \t40 ML  \t  \t  DEXAMETHASONE SODIUM PHOSPHATE (P.F.) 8MG/ML (800MCG/0.1ML) INJECTABLE\t0.1 ML  DEXAMETHASONE SODIUM PHOSPHATE 40MG/ML INJECTABLE\t50 ML  DEXAMETHASONE SODIUM PHOSPHATE 4MG/ML INJECTABLE\t100 ML  \t  \t  \t180 MLS  \t  \t240 MLS  \t30 ML  \t60 ML  DEXAMETHASONE SODIUM PHOSPHATE IN BSS (P.F.) 10MG/ML (1%) INJECTABLE\t1 ML  \t  \t  DEXAMETHASONE SODIUM PHOSPHATE, 30ML VIAL** 4MG/ML INJECTABLE\t30 ML  DEXAMETHASONE SOLUTION - NACL, P.F. 0.1% OPHTHALMIC\t15 ML  \t  \t  DEXAMETHASONE, SDPF - (0.07ML SYRINGE, 30G, 1/2\") 80MG/ML INJECTABLE\t0.35 ML  \t  \t0.7 ML", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1498-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "10 units", "code_info": "Rx #'s:  0384839      0384839", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "ISOSULFAN BLUE 1% INJECTABLE\t10 ML  \t  \t15 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1550-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx #'s:  0396686    0404360    0390749    0401266    0401266    0390749    0387231    0404358", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PROCAINE HCL, P.F. 1% INJECTABLE\t1000 ML  \t180 ML;  PROCAINE HCL, P.F. 2% INJECTABLE\t300 ML  \t  \t360 ML  \t450 ML;  PROCAINE HCL, P.F. 8% INJECTABLE\t20 ML  \t60 ML  (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1607-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "32 units", "code_info": "Rx #'s:   0357871    0391634    0371936    0352518    0371936    0390747        0371936        0390747    0400018      0400326    0408192    0402171    0408101    0409503    0398622              0399780    0401796    0401796    0389109    0401003      0383611", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MAGNESIUM CHLORIDE, PRESERVATIVE FREE 20% INJECTABLE\t100 ML  \t  \t1000 ML  \t500 ML  \t  \t  \t  \t  \t600 ML  \t  \t  \t  \t  \t  \t750 ML;  MAGNESIUM SULFATE  50% (500MG/ML) INJECTABLE\t14 ML  \t20 ML  \t4 ML;  \t  MAGNESIUM SULFATE IN 5% DEXTROSE 1% (1GM/100ML) INJECTABLE\t2400 ML;  \t  \t  \t  \t  \t  MAGNESIUM SULFATE IN 5% DEXTROSE 4% (2GM/50ML) INJECTABLE\t1200 ML;  MAGNESIUM SULFATE, P.F. 50% (500MG/ML) INJECTABLE\t180 ML  \t240 ML  \t4 ML  \t  \t  \t6 ML  (14 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1568-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA200403"], "brand_name": ["HYDROMORPHONE HYDROCHLORIDE"], "generic_name": ["HYDROMORPHONE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1283", "0409-2552", "0409-3356", "0409-2540", "0409-3365", "0409-1312", "0409-1304"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["HYDROMORPHONE HYDROCHLORIDE"], "rxcui": ["897653", "897753", "897756", "897757", "897758", "1433251", "1724276", "1724383", "1724644"], "spl_id": ["58ff0e68-b78f-4ebd-a91b-b53bbdefc544"], "spl_set_id": ["e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"], "package_ndc": ["0409-2552-11", "0409-2552-01", "0409-3356-11", "0409-3356-01", "0409-2540-11", "0409-2540-01", "0409-3365-11", "0409-3365-01", "0409-3365-10", "0409-1283-03", "0409-1283-31", "0409-1283-09", "0409-1283-10", "0409-1283-04", "0409-1283-05", "0409-1312-03", "0409-1312-30", "0409-1312-09", "0409-1312-10", "0409-1304-03", "0409-1304-31"], "is_original_packager": [true], "unii": ["L960UP2KRW"]}, "product_type": "Drugs", "event_id": "61847", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-1444-2012", "product_description": "HYDROmorphone HCl Injection, USP, 1 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packaged in 10-count Carpujects per carton, Rx only, Hospira, Inc., Lake Forest, IL  60045, NDC 0409-1283-31, Barcode (01) 1 030409 128331 9 (carton), (01) 0 030409 128331 2 (cartridge unit).", "product_quantity": "223,750 prefilled cartridge units", "reason_for_recall": "Superpotent (Single Ingredient) Drug: Some of the prefilled cartridge units have been found to be overfilled and contain more than the 1 mL labeled fill volume.", "recall_initiation_date": "20120512", "center_classification_date": "20120807", "termination_date": "20150529", "report_date": "20120815", "code_info": "Lot #07547LL, Exp 07/01/13", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0394926", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PAPAVERINE/PHENTOLAMINE/ATROPINE  NS 3.6MG/0.4MG/0.04MG INJECTABLE\t13 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1595-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62541", "recalling_firm": "Victus, Inc.", "address_1": "4918 SW 74th Ct", "address_2": "N/A", "postal_code": "33155-4400", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL", "recall_number": "D-1652-2012", "product_description": "Hipoglos Ointment (zinc oxide and lanolin), Helps prevent and treat diaper rash, skin irritation, Manufactured by Laboratorios Andromaco S.A. Av. Quilin 5273, Penalolen, Santiago. www.hipoglos.cl, www.laboratoriosandromaco.cl, Made in Chile, Net wt. per Tube: a) 0.18 oz (5 g), NDC: 50145-111-05;  b) 2.2 oz (60 g), NDC: 50145-111-04; c) 2.5 oz (72 g), NDC: 50145-111-03; d) 3.5 oz (100 g), NDC: 50145-111-02; e) 4.2 oz (120 g), NDC: 50145-111-01.", "product_quantity": "1,535 Tubes", "reason_for_recall": "Misbranded", "recall_initiation_date": "20111110", "center_classification_date": "20120817", "termination_date": "20130725", "report_date": "20120829", "code_info": "Lot #/Product #:   a) C1557B/MM26306, Exp 03/31/2014;   b) C1387B/PV16856, Exp 03/31/2014, G0288C/PV16856, Exp 07/31/2013;   c) G0288A/PV16855, Exp 07/31/2013;  d) G0289B/PV16854, Exp 07/31/2013;  e) C1387A/PV16853, Exp 03/31/2014, G0288B/PV16853, Exp 07/31/2013"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1079 units", "code_info": "Rx #'s:  0385634        0395331                  0382740    0391178    0392393    0402036    0404974    0406412    0348990    0389957          0389256      0398308    0400088    0402379    0368830    0381744          0391578      0393939    0368830    0394696    0394699    0394702    0400088    0370658    0374176      0374332    0377853      0396389    0409606    0397569    0363591      0363906    0364885      0368563    0370643    0374134    0388160    0390765    0391578    0397626    0397664    0405185    0368830    0390948      0360900    0364885    0370658    0371998    0377418    0386488    0387749    0390765    0391251    0392700    0396481        0404354    0408442    0408450    0384787    0364885    0399054    0399978    0407186    0357229    0368830    0369658    0378021    0388340    0392613    0392899    0395705    0396389    0397569    0398713    0401967    0363906    0369658    0374332    0385847    0395772    0389236    0354926    0372478    0389236    0403647    0369615    0372478    0403647    0398727    0356719    0384919      0358078    0405425    0364078    0361229              0355028    0363367    0387510    0393522      0396503    0396748    0402531    0403762    0381124      0389376    0390757    0397155    0403061    0407722    0402531    0409835    0360794      0367718    0380495    0399205    0392377        0375206          0366326      0389376    0390757    0392377    0375206        0393522    0399205    0406462    0392377    0381206    0379957        0386978    0387228    0381206      0405721    0379957      0386978    0388312    0355234    0395430    0396345    0397113    0397206    0398817      0364094    0390534    0395074    0381540    0355612    0356043    0381225    0389512    0398817        0406027    0398694      0390534    0397464    0356043    0364094    0376377    0390194    0390768    0396674    0402214    0408184    0393442    0364094    0396343    0399934    0379020    0404494      0365952          0385380      0379020      0406986    0363729        0366561    0404494    0371056    0407417    0393442      0392768    0394298    0394606    0397253    0403210    0403347    0406699    0407892    0408311    0355056      0361444    0367534    0367592    0373176    0379506    0388023    0398878    0366168    0367534    0373176      0385023    0389065    0408083    0410227    0367592    0388249    0396642    0398122    0408087    0385991    0367534    0378631    0390829    0392453    0395572    0395650    0395824    0396106    0396417    0399802    0401313      0401636    0407069    0408311    0367592    0405638    0408667    0356337    0387887    0387973      0398326        0354974    0385991        0360653    0368998    0383647      0386367    0401638    0404139    0401960    0352358    0363847    0368488    0376511    0379506        0388170          0394298    0395650    0395898    0396265    0402035    0405424    0388023    0390528    0398974    0363108      0368488    0376484        0377711    0379506    0383647    0383963      0383964    0386977      0389901    0395650    0396106    0397928    0398012    0399791    0400411    0401313    0401367      0404852    0406516    0406559    0409054    0409493    0358706    0366168    0388023    0385991    0356048    0390829    0399052    0404405    0358706    0364163    0368438                  0373628    0378415    0380729    0384022      0384820    0384924            0386712    0387628    0387865    0388826    0389073    0390173    0390513      0390518      0390718    0391743    0392014    0394543    0394720    0396104    0396816    0397072    0397419    0399203    0399386      0400178          0401617    0404283        0404700    0407235    0408221    0409542    0395110      0354218    0356050    0356327    0357403      0358003    0358929    0359280    0369134    0369611    0376117    0377566    0383704      0385106      0387713    0387750    0390828    0390946    0391451    0393749      0394531    0395077    0396798    0398991    0399005    0402840    0403368    0403373    0403783    0406711    0378537    0398212    0356050    0359583    0364548    0356679      0357791    0363049    0364936    0367239    0369134            0370023          0373956      0376260    0376320        0378647    0385669    0386712    0386728    0387706    0390516        0390582    0393749          0393750    0395077    0396563    0398214    0399267    0399427      0400465      0403478    0405056    0406904    0408321    0408323    0408782    0408851    0409600    0358139      0361373    0389055    0399571        0386086    0395077    0404402    0409082    0357126    0396419    0395077      0354088    0377073    0385106      0390516      0390582    0394621    0401223      0395077      0391517    0395077    0406365    0395077    0354088    0409434    0395077    0353042    0355236    0355741    0357825    0365251    0372377    0375561        0379898      0382826    0383962    0384022      0384924    0389359    0389743    0390582    0392165        0393457    0394495    0394543    0395134      0395508    0395740        0396450    0396518      0396646    0396816        0398780      0398851      0404013    0404699      0404700    0405413    0408164    0395110    0400486    0408927    0357791    0359618    0364936    0369611    0384820    0387750          0392194    0397577    0399005    0400973      0401482    0408304    0359542    0395077    0395077    0354963    0360217    0391978    0398044    0398667    0404323    0353729    0353865    0354218      0356046    0358187    0359583    0365315    0367667    0371838    0373520    0374413    0375806      0376320    0376927    0381501      0382825    0383066        0383704    0383962    0384465    0385984    0386979    0387539    0387706    0388534    0389466    0389585    0389743    0393457      0394543      0394859    0395508    0395602          0395740    0396518        0399213        0401861    0402198    0404199    0406508      0406659      0407374    0407843      0408383    0409753    0397128        0357793    0363902    0390516      0401223      0401482    0358931        0352357    0355240    0359289    0364548      0364695      0367998    0368184    0372377    0373628    0375378    0378647    0378649    0381501    0384820        0385106      0386086    0386173    0386332      0386979    0388534    0388663        0390218    0390389    0390518    0391172    0391258    0391283    0391296    0391799    0393457    0393749    0395134    0396518    0404013    0404108    0404283      0406982    0407388    0408758    0410018    0378537      0359618      0364730    0371189      0401482    0354088    0359289    0362308    0364163    0368184        0375806    0378415    0381901    0383704    0385106    0387539    0387865    0388534    0388826    0389743    0389810    0390516    0391234    0391743    0392807    0394258    0395128    0396816    0399377    0404013    0405630    0389055    0371189    0394299    0395077    0353449    0353729    0353865    0354732    0354913      0354963    0355240      0355628      0356046    0356304    0357126          0357677        0357888        0359106    0359289    0359341    0359698        0361085      0361327      0362308    0362611        0363049    0364163        0368105      0368438        0371592                0373956          0374017    0375142    0375378      0375766    0375806    0376260    0376927      0378415        0378647      0378649            0381035          0381501    0382827        0385024          0385106        0385448        0385669    0385984    0386080    0386712    0387467    0387539        0387675    0387706      0387871    0389070    0389743    0389850      0390059      0390838      0390945    0391284    0391511    0391628      0391743    0392009    0392097    0392172    0392403    0392406    0392550    0392842    0393749    0394127    0394252    0394258    0394531    0394720      0395038    0395128      0395436    0395721    0396798    0396816      0396879    0396969      0397072      0397171    0397190    0397303    0397645    0398046    0398138    0398139    0398830    0398991    0399028        0399068    0399223    0399377      0400422    0400465    0400634      0400722    0400966    0401243    0401582    0401900    0401938    0402188    0402191    0402209    0403106    0403669    0404199    0404308    0404465    0404524    0404725    0404903    0404964    0405161    0405210    0405908    0406206    0406678      0406982    0407579    0407584    0408199    0408201    0408468    0409075    0409538    0409580    0409589    0409591    0409705    0409844    0409847    0410320    0378537      0388863                0389055    0394218    0399571    0354088    0387539    0399803    0401011    0404283    0352357    0354088    0354238      0355240      0357677    0359106    0359583    0363624      0368996    0369084    0384127    0385106      0386086    0386173    0388309    0388311    0388314    0389238    0392448    0394531      0395128      0396012    0396798    0396934    0398273    0399028    0399036    0400465    0400634    0400641    0400937    0401910    0402479    0402539    0403346    0404741      0405675    0405719    0406900    0407235    0407799    0408746    0408832    0367324    0380605    0388863    0354088      0376320    0378844    0379039    0384820    0385024    0386086    0391531    0394767    0395077    0404308    0390240    0383248    0400817    0383248    0395901    0402029    0388395    0394585    0391474", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MITOMYCIN 1MG/ML SOLUTION\t160 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t40 ML  \t  \t  \t  \t  \t  \t80 ML;  \t  \t  \t  \t  MITOMYCIN SOLUTION, STERILE 0.02% (200MCG/ML) OPHTHALMIC\t0.5 ML  \t  \t  \t  \t  \t1 ML  \t  \t  \t  \t  \t  \t  \t  \t1.5 ML  \t  \t  \t  \t  \t10 ML  \t  \t  \t  \t  \t  \t  \t  \t12.5 ML  \t2 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2.5 ML  \t  \t  \t3 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t30 ML  \t4 ML  \t  \t  \t  \t5 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t6 ML  \t  \t  \t  \t7 ML;  MITOMYCIN SOLUTION, STERILE 0.025% (250MCG/ML) OPHTHALMIC\t2 ML  \t3 ML  \t  \t  \t  \t4 ML  \t  \t6 ML  MITOMYCIN SOLUTION, STERILE 0.03% (300MCG/ML) OPHTHALMIC\t2 ML  \t3 ML  \t  \t  \t4 ML  \t  \t5 ML;  MITOMYCIN SOLUTION, STERILE 0.04% (400MCG/ML) OPHTHALMIC\t1 ML  \t  \t  \t  \t  \t  \t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t12 ML  \t  \t  \t2 ML  \t  \t  \t  \t20 ML  \t  \t3 ML  \t  \t  \t  \t  \t3.6 ML  \t  \t  \t4 ML  \t  \t  \t  \t5 ML  \t  \t  \t  \t5.4 ML  \t6 ML  \t  \t  \t  \t  \t  \t7.2 ML;  MITOMYCIN SOLUTION, STERILE 0.05% (500MCG/ML) OPHTHALMIC\t1.5 ML  \t10 ML  \t  \t  \t  \t15 ML  \t2 ML  \t  \t3 ML  \t5 ML;  \t  \t  MITOMYCIN SOLUTION, STERILE/BUFFERED 0.5MG/ML INJECTABLE\t80 ML;  MITOMYCIN, LYOPHILIZED  1MG INJECTABLE\t1 VIAL  \t  \t  \t  \t  \t  \t  \t10 VIAL  \t  \t  \t12 VIAL  \t2 VIAL  \t  \t  \t  \t  \t  \t  \t  \t2 VIALS  \t  \t20 VIAL  \t20 vials  \t3 VIAL  \t  \t  \t  \t  \t  \t  \t  \t3 VIALS  \t4 VIAL  \t  \t  \t4 VIALS  \t  \t  \t5 VIAL  \t  \t  \t  \t  \t  \t5 VIALS  \t  \t50 VIAL  \t6 VIAL  \t  \t  \t  \t6 VIALS  \t8 VIAL  \t  \t8 VIALS;  \t  MITOMYCIN, LYOPHILIZED (BUFFERED) 20MG INJECTABLE\t1 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t10 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t12 VIAL  \t  \t  \t  \t  \t  \t  \t  \t15 VIAL  \t  \t  \t  \t16 VIAL  \t17 VIALS  \t18 VIAL  \t2 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t20 VIAL  \t  \t  \t24 VIAL  \t  \t  \t  \t  \t  \t  \t24 VIALS  \t  \t  \t  \t3 VIAL  \t  \t  \t  \t  \t  \t  \t30 VIAL  \t4 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t5 VIAL  \t  \t  \t6 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t6 VIALS  \t7 VIAL  \t  \t7 VIALS  \t8 VIAL  \t  \t  \t  \t8 VIALS;  MITOMYCIN, LYOPHILIZED (BUFFERED) 40MG INJECTABLE\t1 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t1 VIALS  \t  \t10 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t10 VIALS  \t  \t11 VIAL  \t  \t  \t12 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t12 VIALS  \t  \t  \t  \t  \t  \t  \t13 VIAL  \t  \t  \t  \t14 VIAL  \t  \t15 `VIAL  \t  \t15 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t16 `VIAL  \t  \t16 VIAL  \t  \t  \t17 `VIAL  \t18 VIAL  \t18 VIALS  \t2 `VIAL  \t2 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2 VIALS  \t  \t  \t20 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t20 vials  \t23 `VIAL  \t23 VIAL  \t24 VIAL  \t  \t  \t  \t  \t  \t3 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t3 VIALS  \t  \t  \t30 VIAL  \t  \t  \t  \t  \t  \t  \t36 VIAL  \t  \t  \t4 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t4 VIALS  \t  \t40 VIAL  \t  \t  \t  \t  \t  \t41 VIAL  \t5 VIAL  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t5 VIALS  \t50 VIAL  \t  \t6 `VIAL  \t6 VIAL", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1581-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #:  0384672", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DMSO/HEPARIN/METHYLPREDNISOLONE 50%/5000U/40MG/50ML SOLUTION 300 MLS (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1507-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:   0400975    0409215    0395770      0359811", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "G-C-P 0.1%/0.1%/0.05% SOLUTION 250 ML, 250 MLS, 500 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1527-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Woodcliff Lake", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "61108", "recalling_firm": "Eagle Pharmaceuticals Inc.", "address_1": "470 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "07677-7604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "New Jersey", "recall_number": "D-1429-2012", "product_description": "Argatroban Injection 50 mg per 50ml (1 mg per ml)  For Intravenous Infusion Only, a) Single Use Vial (NDC 42367-203-07),  b) 10 Single Use Vials(NDC 42367-203-84), Rx Only, Manufactured by: Cipla LTD, India, Manufactured for: Eagle Pharmaceuticals, Inc.  Woodcliff Lake, NJ  07677 USA, Marketed by: The Medicines Company, Parsippany, NJ 07054 USA", "product_quantity": "19,660 vials", "reason_for_recall": "A complaint was received from a hospital pharmacy on 11/10/11 for crystalline particulates in a single vial from Lot V10194. Additional small visible particles consisting of fibers were identified.", "recall_initiation_date": "20111202", "center_classification_date": "20120731", "termination_date": "20130603", "report_date": "20120808", "code_info": "Lot #V10189, Lot #V10191, Lot #V10194,  Exp 01/13; Lot #V10223; Exp 02/13"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:  0353549      0398279", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CHROMIUM PICOLINATE 200MCG/ML INJECTABLE 60 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1484-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:  0406632    0390375", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PAPAVERINE/ALPROSTADIL 30MG/10MCG/ML INJECTABLE\t10 ML;  PAPAVERINE/ALPROSTADIL 30MG/15MCG/ML INJECTABLE\t10 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1594-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076131"], "brand_name": ["PACLITAXEL"], "generic_name": ["PACLITAXEL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-015", "61703-342"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PACLITAXEL"], "rxcui": ["312199"], "spl_id": ["f4f04a49-a3f6-40cd-b261-aa889a0b7d0d"], "spl_set_id": ["ea28753a-8631-460a-bfdc-b101eb8ac84a"], "package_ndc": ["61703-342-09", "61703-342-22", "61703-342-50", "61703-015-04"], "is_original_packager": [true], "nui": ["N0000175085", "N0000175592"], "pharm_class_pe": ["Microtubule Inhibition [PE]"], "pharm_class_epc": ["Microtubule Inhibitor [EPC]"], "unii": ["P88XT4IS4D"]}, "product_type": "Drugs", "event_id": "62459", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, including Puerto Rico and Guam.    Product was also distributed internationally to Australia, Belgium, Canada, France, Germany, Korea, Malaysia, New Zealand, Norway, Pakistan, Philippines, Portugal, Singapore, Sweden, Thailand and  Vietnam", "recall_number": "D-1682-2012", "product_description": "Paclitaxel Injection, 6 mg/mL, 50 mL Single Dose Vial, Rx only, antineoplastic/cytotoxic agent; Manufactured for Hospira, Inc., Lake Forest, IL 60045, Product of Australia; N DC 61703-342-50", "product_quantity": "131,264 vials", "reason_for_recall": "The affected lots of Carboplatin Injection, Cytarabine  Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.", "recall_initiation_date": "20120627", "center_classification_date": "20120919", "termination_date": "20161215", "report_date": "20120926", "code_info": "lot numbers Y096865AA, exp AUG 2013; Y106865AA, exp AUG 2013; Y116865AA, exp AUG 2013; Y126865AA, exp SEP 2013; Y136865AA, exp SEP 2013; Y146865AA, exp SEP 2013; Y156865AA, exp OCT 2013; Y166865AA, exp NOV 2013; Y176865AA, exp NOV 2013; and Y186865AA, exp DEC 2013", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "16 units", "code_info": "Rx #'s:   0403973    0408102    0403973    0409770    0403973    0403973    0400158    0400507    0400959    0402186    0398525    0400507    0400959    0398520    0400995    0400997", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "ONDANSETRON HCL, MDV 2MG/ML (40MG/20ML) INJECTABLE\t200 ML  \t40 ML  \t400 ML  \t48 ML  \t600 ML  \t800 ML;  ONDANSETRON HCL, P.F. 2MG/ML (4MG/2ML) INJECTABLE\t20 ML  \t  \t  \t  \t200 ML  \t24 ML  \t40 ML  \t48 ML  (11 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1589-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1193 units", "code_info": "Rx #'s:C0389434  C0389437  C0389439  C0389440  C0389441  C0389442  C0389444  C0389445  C0389446  C0389447  C0389448  C0389449  C0389450  C0389451  C0389452  C0389453  C0389454  C0389455  C0391550    C0397034  C0402354  C0372981  C0377330  C0380467  C0380957  C0381304  C0382133  C0383978  C0384095    C0385948  C0385973  C0385977  C0385980  C0386103    C0387091  C0387437  C0387546  C0387549  C0387587  C0387588  C0387589  C0387733  C0387734  C0387736  C0387738  C0387753  C0388095  C0388096  C0388097  C0388098  C0388099  C0388100  C0388101  C0388107  C0388208  C0388209  C0388211  C0388212  C0388216  C0388217  C0388247  C0388248  C0388341  C0388349  C0388379  C0388875  C0388877  C0388878  C0388879  C0388881  C0388948  C0388950  C0388951  C0388952  C0388954  C0388956  C0388959  C0388961  C0388964  C0388965  C0388967  C0388968  C0388969  C0388970  C0388971  C0388972  C0388973  C0388975  C0388976  C0388977  C0388978  C0388979  C0388982  C0388984  C0388986  C0388987  C0388990  C0388994  C0388997  C0388998  C0389000  C0389002  C0389003  C0389005  C0389007  C0389008  C0389010  C0389011  C0389013  C0389014  C0389016  C0389018  C0389019  C0389020  C0389021  C0389024  C0389028  C0389413  C0389415  C0389685  C0389738  C0389822    C0389917  C0389918  C0389919  C0389921  C0389923  C0389925  C0389927  C0389929  C0389931  C0389932  C0389933  C0389935  C0389937  C0389938  C0389939  C0389940  C0389942  C0389943  C0389945  C0389958  C0389959  C0389960  C0389961  C0389962  C0389964  C0389966  C0389969  C0389970  C0389971  C0389980  C0389990  C0390034  C0390035  C0390257  C0390258  C0390259  C0390263  C0390266  C0390268  C0390270  C0390274  C0390281  C0390283  C0390287  C0390290  C0390378  C0390381  C0390386  C0390432  C0390435  C0390436  C0390437  C0390438  C0390439  C0390440  C0390441  C0390442  C0390443  C0390444  C0390446  C0390447  C0390448  C0390449  C0390450  C0390451  C0390452  C0390453  C0390454  C0390666  C0390667  C0390669  C0390670  C0390683  C0390685  C0390687  C0390688  C0390690  C0390691  C0390694  C0390696  C0390698  C0390699  C0390701  C0390707  C0390711  C0390712  C0390750  C0390752  C0390753  C0390756  C0390758  C0390759  C0390760  C0390762  C0390767  C0390769  C0390778  C0390780  C0390785  C0390795  C0390796  C0390797  C0391096  C0391193  C0391194  C0391364    C0391365    C0391366    C0391367    C0391368    C0391369    C0391379  C0391380  C0391398  C0391504  C0391613    C0391616  C0391619    C0391622    C0391870  C0391874  C0391966    C0392116    C0392142    C0392350  C0392458  C0392461  C0392463  C0392464  C0392465  C0392466  C0392468  C0392471  C0392472  C0392474  C0392475  C0392476  C0392477  C0392478  C0392479  C0392480  C0392481  C0392482  C0392483  C0392484  C0392485  C0392486  C0392487  C0392488  C0392489  C0392490  C0392491  C0392492  C0392493  C0392494  C0392495  C0392496  C0392497  C0392498  C0392499  C0392500  C0392501  C0392504  C0392722  C0392728  C0392738  C0392739  C0392742  C0392746  C0392749  C0392754  C0392757  C0392760  C0392761  C0392763  C0393120  C0393135  C0393137  C0393138  C0393139  C0393140  C0393142  C0393143  C0393144  C0393145  C0393146  C0393147  C0393148  C0393149  C0393151  C0393152  C0393153  C0393154  C0393155  C0393157  C0393159  C0393182  C0393259  C0393260  C0393265  C0393466  C0393551  C0393627  C0393631  C0393632  C0393638  C0393719  C0393720  C0393721  C0393763  C0393780      C0393834  C0393840  C0393842  C0393845  C0393847  C0393849  C0393850  C0393851  C0393853  C0393854  C0393855  C0393856  C0393858  C0393860  C0393861  C0393862  C0393863  C0393865  C0393867  C0393868  C0393870  C0393872  C0393873  C0393875  C0393950  C0393988    C0394308  C0394313    C0394314    C0394884  C0394885  C0394887  C0394888  C0394890  C0394891  C0394912  C0394919  C0394939  C0394940  C0394952  C0394953  C0394956  C0394958  C0394962  C0395009  C0395012  C0395014  C0395015  C0395018  C0395020  C0395021  C0395022  C0395023  C0395024  C0395026  C0395027  C0395028  C0395029  C0395030  C0395073  C0395076  C0395588    C0396178  C0396305  C0396307  C0396308  C0396309  C0396310  C0396316  C0396320  C0396341  C0396407  C0396457  C0396480    C0396551    C0396552    C0396936    C0397031  C0397044  C0397049  C0397050  C0397055  C0397057  C0397058  C0397062  C0397318  C0397320  C0397675  C0398068  C0398072  C0398087  C0398088  C0398090  C0398094  C0398095  C0398096  C0398097  C0398098  C0398099  C0398100  C0398102  C0398104  C0398106  C0398109  C0398112  C0398113  C0398341  C0398342  C0398393  C0398399  C0398401  C0398407  C0398408  C0398410  C0398412  C0398413  C0398414  C0398416  C0398417  C0398418  C0398419  C0398420  C0398421  C0398422  C0398423  C0398424  C0398425  C0398426  C0398427  C0398428  C0398429  C0398431  C0398432  C0398433  C0398434  C0398435  C0398436  C0398437  C0398438  C0398439  C0398440  C0398441  C0398442  C0398443  C0398444  C0398445  C0398446  C0398447  C0398448  C0398449  C0398450  C0398451  C0398452  C0398453  C0398454  C0398455  C0398456  C0398457  C0398458  C0398459  C0398460  C0398461  C0398462  C0398463  C0398464  C0398465  C0398466  C0398467  C0398468  C0398469  C0398470  C0398471  C0398472  C0398473  C0398474  C0398475  C0398476  C0398477  C0398478  C0398479  C0398480  C0398481  C0398482  C0398483  C0398484  C0398485  C0398486  C0398487  C0398488  C0398489  C0398490  C0398491  C0398492  C0398493  C0398494  C0398495  C0398496  C0398497  C0398498  C0398499  C0398558  C0398560  C0398561  C0398749  C0398750  C0398752  C0398754  C0398756  C0398797  C0398806  C0398944  C0398946  C0398947  C0399113  C0399115  C0399116  C0399117  C0399118  C0399119  C0399120  C0399121  C0399122  C0399204  C0399210  C0399212  C0399306  C0399308  C0399309  C0399310  C0399311  C0399313  C0399314  C0399315  C0399316  C0399317  C0399318  C0399321  C0399389  C0399391  C0399589  C0399592  C0399593  C0399594  C0399595  C0399596  C0399840  C0400185  C0400186  C0400188  C0400313  C0400316  C0400318  C0400321  C0400323  C0400324  C0400330  C0400357  C0400358  C0400361  C0400363  C0400365  C0400366  C0400368  C0400369  C0400370  C0400371  C0400376  C0400379  C0400381  C0400386  C0400387  C0400389  C0400390  C0400391  C0400392  C0400538  C0400541  C0400812  C0400820  C0400852  C0400854  C0400858  C0400860  C0401161  C0401257  C0401988  C0402422  C0402424  C0402428  C0402430  C0402434  C0402438  C0402441  C0402442  C0402444  C0402445  C0402447  C0402450  C0402452  C0402454  C0402455  C0402456  C0402458  C0402459  C0402461  C0402462  C0402463  C0402885  C0402886  C0402887  C0402888  C0402937  C0403305  C0403378  C0403397  C0403495  C0403496  C0403527  C0403624  C0403794  C0403864  C0403865  C0403866  C0403868  C0403870  C0403872  C0404368  C0404370  C0404642  C0404935  C0405125  C0405126  C0405127  C0405128  C0405129  C0405130  C0405131  C0405132  C0405133  C0405134  C0405135  C0405136  C0405137  C0405138  C0405139  C0405345  C0405511  C0405537  C0405539  C0405549  C0405551  C0405559  C0405815  C0405833  C0405839  C0405854  C0406127  C0406137  C0406139  C0406140  C0406236  C0406240  C0406378  C0406381  C0406383  C0406788  C0406876  C0407040  C0407189  C0407191  C0407193  C0407195  C0407197  C0407201  C0407203  C0407204  C0407206  C0407210  C0407212  C0407215  C0407216  C0407217  C0407259  C0407273  C0407275  C0407276  C0407278  C0407280  C0407282  C0407305  C0407316  C0407317  C0407319  C0407328  C0407331  C0407333  C0407335  C0407570  C0407678  C0407679  C0407681  C0407682  C0407683  C0407687  C0407689  C0407690  C0407692  C0407694  C0407695  C0407696  C0407697  C0407837  C0407840  C0407882  C0407883  C0407898  C0407899  C0407901  C0407902  C0407904  C0407906  C0407976  C0407977  C0407980  C0407982  C0407984  C0407985  C0407986  C0408008  C0408017  C0408019  C0408020  C0408217  C0408220  C0408249  C0408402  C0408406  C0408408  C0408411  C0408412  C0408413  C0408414  C0408416  C0408418  C0408420  C0408422  C0408424  C0408425  C0408426  C0408429  C0408431  C0408432  C0408433  C0408434  C0408435  C0408437  C0408439  C0408440  C0408441  C0408443  C0408444  C0408445  C0408446  C0408448  C0408452  C0408455  C0408456  C0408457  C0408460  C0408461  C0408463  C0408464  C0408465  C0408466  C0408469  C0408472  C0408479  C0408481  C0408483  C0408484  C0408485  C0408488  C0408492  C0408493  C0408495  C0408507  C0408508  C0408509  C0408513  C0408518  C0408528  C0408531  C0408532  C0408533  C0408534  C0408541  C0408542  C0408543  C0408553  C0408558  C0408569  C0408571  C0408574  C0408577  C0408579  C0408580  C0408581  C0408582  C0408584  C0408586  C0408588  C0408590  C0408591  C0408592  C0408593  C0408594  C0408596  C0408597  C0408606  C0408607  C0408608  C0408627  C0408628  C0408629  C0408635  C0408646  C0408647  C0408648  C0408655  C0408656  C0408657  C0408905  C0409134  C0409136  C0409140  C0409141  C0409142  C0409143  C0409210  C0409334  C0409637  C0409639  C0409640  C0409642  C0409643  C0409645  C0409648  C0409649  C0409651  C0409653  C0409657  C0409668  C0409670  C0409675  C0409682  C0409686  C0409687  C0409688  C0409690  C0409693  C0409696  C0409748  C0409750  C0409754  C0391538  C0388196  C0388439  C0388454  C0390740  C0390741  C0390742  C0390743  C0390744  C0390745  C0392558  C0392727  C0394387  C0394806  C0394808  C0394810  C0394812  C0394813  C0394815  C0394816  C0394817  C0394818  C0394819  C0394822  C0394823  C0397368  C0399961  C0399967  C0400574  C0400580  C0400582  C0400586  C0400589  C0400592  C0400593  C0400596  C0400600  C0400602  C0400605  C0400607  C0403652  C0403653  C0403655  C0403656  C0403658  C0403659  C0403661  C0403667  C0403670  C0403671  C0403672  C0403675  C0403679  C0403681  C0403684  C0403685  C0403688  C0403690  C0403699  C0403703  C0403705  C0403706  C0403707  C0403708  C0403709  C0403716  C0403717  C0403962  C0403965  C0403966  C0403967  C0403969  C0403970  C0403971  C0403974  C0403975  C0403978  C0403980  C0403981  C0404151  C0404361  C0404393  C0405479  C0405808  C0406203  C0406420  C0406652  C0407055  C0407056  C0407060  C0407063  C0407066  C0407068  C0407071  C0407075  C0407076  C0407077  C0407089  C0407090  C0407091  C0407093  C0407094  C0407097  C0407098  C0407099  C0407104  C0407109  C0407114  C0407115  C0407125  C0407130  C0407131  C0407137  C0407141  C0407142  C0407149  C0407150  C0407151  C0407152  C0407593  C0407823  C0408239  C0408247  C0408258  C0408261  C0408263  C0408273  C0408282  C0408286  C0408288  C0408291  C0408293  C0408294  C0408524  C0409224  C0389431  C0400348  C0405848  C0400181  C0385989        C0387410        C0395585  C0409001  C0410097  C0387938  C0387939  C0390264  C0390612  C0390799  C0393032    C0394401  C0394402  C0394406  C0394411  C0394412  C0394421  C0394911  C0397033  C0397035  C0397052  C0397053  C0397056  C0397059  C0402127  C0403071  C0403072  C0403074  C0403092  C0403230  C0404392  C0404882  C0404884  C0404888  C0405616  C0405829  C0405845  C0405852  C0409919  C0398505  C0397373  C0405192  C0390937  C0391534  C0389190  C0379575  C0379730  C0393090  C0393436  C0393458  C0394915  C0401063  C0401064  C0405248    C0407719  C0409133  C0410114  C0387542  C0387788  C0389364  C0389576  C0390789  C0391052  C0391705  C0392428    C0393672  C0393705    C0394343  C0395670  C0397735    C0399114  C0399123  C0399124  C0399974  C0400164  C0403477  C0404042  C0405970  C0405990  C0406189  C0407782  C0410324  C0401084  C0407386  C0403187  C0391098  C0391110  C0391112  C0391115  C0391120  C0391123  C0396129  C0396130  C0396132  C0396133  C0396134  C0396135  C0401156  C0401162  C0401163  C0401164  C0401166  C0401167  C0408842  C0408844  C0408847  C0408849  C0408853  C0408856  C0374117  C0398680  C0383122  C0383125  C0383148  C0383149  C0391033  C0405334  C0405335  C0405338  C0391033", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "ULTRA-TEST 200 (CYP 80%/PROP 20%) 200MG/ML INJECTABLE\t1 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t10 MLS  \t12 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t15 ML  \t  \t  \t18 ML  \t2 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t20 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t20 MLS  \t24 ML  \t  \t3 ML  \t  \t30 ML  \t5 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t6 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t8 ML  \t  \t9 ML;  ULTRA-TEST 200 IN SESAME OIL (CYP 80%/PROP 20%) 200MG/ML INJECTABLE\t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t30 ML  \t8 ML;  ULTRA-TEST 250 (CYP 80%/PROP 20%) 250MG/ML INJECTABLE\t10 ML  \t  \t  \t  \t  \t  \t  \t  \t20 ML  (21 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1636-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "78 units", "code_info": "Rx #'s:  0391506      0387832      0379379                        0384684    0393073    0401183    0362996    0390985    0391304    0391536    0401641    0405794    0381389    0354014      0394430    0376201    0391434    0391655    0399075    0399950    0400595    0401944    0406909    0408906    0408911    0409594    0409904    0394430        0406648    0372200        0387977    0389172    0390806    0392300    0392584    0394307    0394757    0398054    0398203    0399720    0400786    0402244    0402746    0406118    0406497    0409911    0410108    0394860    0363347      0406812    0394712      0374379      0395812    0402219      0371817    0380501    0403485", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "METHIONINE/INOSITOL/CHOLINE CHLORIDE/CHROM/B12 (C) 0.8/1.6/1.6/0.0001/0.03% INJE\t10 ML  \t  \t200 ML  \t  \t30 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t50 ML;  METHIONINE/INOSITOL/CHOLINE CHLORIDE/CHROM/B12 (M) 0.8/1.6/1.6/0.0001/0.03% INJE\t10 ML  \t  \t  \t  \t  \t  \t150 ML  \t180 ML  \t  \t  \t30 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t360 ML  \t  \t  \t4 ML  \t5 ML;  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  METHIONINE/INOSITOL/CHOLINE CHLORIDE/CHROM/VIT B-12  0.8/1.6/1.6/0.0001/0.03% IN\t30 ML;  METHIONINE/INOSITOL/CHOLINE CHLORIDE/CHROMIUM CHLORIDE 0.8/1.6/1.6/0.0001/0.03% \t100 ML  \t  \t  \t30 ML  \t  \t80 ML;  \t  METHIONINE/INOSITOL/CHOLINE CHLORIDE/VIT B12 0.8%/1.6%/1.6%/1200MCG/ML INJECTABL\t30 ML;  METHIONINE/INOSITOL/CHOLINE CL/B6/B12/CHROM/ (C)           25/50/50/100/1MG/4MCG\t5 ML;  \t  METHIONINE/INOSITOL/CHOLINE/CHROMIUM W/O B-12 0.8/1.6/1.6/0.0001% INJECTABLE\t30 ML  (18 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1572-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "24 units", "code_info": "Rx #'s:  0395804      0395804    0404876    0405488    0404876    0403179    0403991    0407590      0407590    0394748    0394749    0403382    0405156    0401795    0401795    0400457    0400944    0392902    0406332    0398643    0405500    0397467", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "SODIUM BICARBONATE 4% INJECTABLE\t10 ML  \t  \t5 ML;  SODIUM BICARBONATE 8.4% INJECTABLE\t150 ML  \t50 ML  \t5000 ML;  SODIUM BICARBONATE, 50ML SDV** 8.4% (1MEQ/ML) INJECTABLE\t100 MLS  \t250 ML;  SODIUM BICARBONATE, MDV 8.4% INJECTABLE\t100 ML  \t  \t150 ML  \t200 ML;  \t  SODIUM CHLORIDE  0.9% (25X10ML) INJ. SDPF **** 0.9% INJECTABLE\t25 VIAL  \t40 ML;  SODIUM CHLORIDE (STERILE) 23.4% (20MEQ/5ML) SOLUTION\t1000 ML  \t2500 ML;  SODIUM CHLORIDE 0.9%  BACTERIOSTATIC ** 0.9% INJECTABLE\t30 MLS  \t750 ML;  SODIUM CHLORIDE 0.9%  IRRIGATION (24X250ML)** 0.9% SOLUTION\t250 ML;  SODIUM CHLORIDE 0.9%, 100ML I.V. BAG** 0.9% INJECTABLE\t100 ML;  SODIUM TETRADECYL SO4 3% INJECTABLE\t20 ML;  \t  SODIUM TETRADECYL SULFATE  0.2 % INJECTABLE\t30 ML  (20 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1618-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "25 units", "code_info": "Rx #'s:  0405994    0401042    0405007    0405945    0404546    0404819    0400172    0404384    0400172    0410164    0410169    0410172    0404101      0404101      0404546    0405739    0393586      0393587      0403026      0401576", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "VORICONAZOLE OPHTHALMIC 1% (10MG/ML) SOLUTION\t15 ML;  VORICONAZOLE OPHTHALMIC, (0.5ML, LL SYRINGE), P.F. 0.1% (100MCG/0.1ML) INJECTABL\t0.5 ML  \t  \t  \t1 ML  \t  \t1.5 ML  \t  \t2 ML  \t  \t  \t  \t2.5 ML  \t  \t5 ML;  \t  \t  \t  VORICONAZOLE OPHTHALMIC, P.F. (SINGLE DOSE ONLY) 0.1% (100MCG/0.1ML) INJECTABLE\t0.1 ML  \t  \t  \t  \t1 ML  \t  \t5 ML  (10 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1642-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077183"], "brand_name": ["AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE"], "generic_name": ["AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE"], "manufacturer_name": ["Dr.Reddy's Laboratories Limited"], "product_ndc": ["55111-338", "55111-339", "55111-340", "55111-341"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "BENAZEPRIL HYDROCHLORIDE"], "rxcui": ["898342", "898350", "898353", "898356"], "spl_id": ["6fafdf6a-6153-9a62-1774-755f2bcf0cc2"], "spl_set_id": ["ca014f06-982c-6fe1-9948-a3701dd35d34"], "package_ndc": ["55111-338-30", "55111-338-01", "55111-338-05", "55111-339-30", "55111-339-01", "55111-339-05", "55111-340-30", "55111-340-01", "55111-340-05", "55111-341-30", "55111-341-01", "55111-341-05"], "is_original_packager": [true], "upc": ["0355111339014", "0355111340010"], "unii": ["864V2Q084H", "N1SN99T69T"]}, "product_type": "Drugs", "event_id": "62591", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "200 Somerset Corporate Blvd Fl 7th", "address_2": "N/A", "postal_code": "08807-2862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1434-2012", "product_description": "Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg,  500 Capsules, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-340-05", "product_quantity": "1656 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets.", "recall_initiation_date": "20120409", "center_classification_date": "20120731", "termination_date": "20130124", "report_date": "20120808", "code_info": "C201293  Exp Date 08/2013"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "48 units", "code_info": "Rx #'s:   0389566        0391189      0400011    0363726        0384953        0389818      0389944    0391513    0394424    0398045    0399810    0400508      0400659      0400899    0402416    0406767    0408616    0408784    0409002    0394645    0404250    0404253    0383078    0390794    0396149    0407773    0380431    0400011    0408013    0385258        0396543        0400011    0386991    0398045", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYDROXYPROGESTERONE CAPROATE 250MG/ML INJECTABLE 10 ML, 12 ML, 13 ML, 15 ML, 3 ML, 30 ML, 4 ML, 5 ML, 6 ML, 7 ML, 9 ML (11 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1544-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx #'s:  0405155    0401813    0405492    0397906    0401484    0401488    0401490    0395651", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "VERAPAMIL HCL 10MG/ML INJECTABLE\t80 ML;  VERAPAMIL HCL 20MG/ML INJECTABLE\t50 ML;  VERAPAMIL HCL, SDV*** (5X2ML VIAL) 2.5MG/ML INJECTABLE\t20 MLS  \t40 ML  \t50 ML  \t  \t  \t50 MLS  (6 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1640-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:C0404989          C0398689  C0403441", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LORAZEPAM 2MG/ML INJECTABLE\t10 ML  \t  \t  \t  \t  \t20 ML  \t200 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1566-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "26 units", "code_info": "Rx #'s:  0387030    0388227    0388955    0389127    0389637    0389994    0391604    0391610    0394004    0394519    0394522    0396467    0396470    0397420    0397616    0399672    0400482    0401216    0401503    0402138    0403400    0403543    0404150    0405978    0362094    0382304", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TETRACAINE HCL OPHTHALMIC 0.05% SOLUTION\t3 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t6 ML;  TETRACAINE HCL P.F. OPHTHALMIC 0.5% SOLUTION\t30 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1622-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "110 units", "code_info": "Rx #'s:N0395099  N0389078  N0389083  N0389084  N0389085  N0389086  N0389089  N0389090  N0389093  N0389095  N0389097  N0389099  N0389100  N0390325  N0390326  N0390328  N0390329  N0390331  N0390332  N0390333  N0390338  N0390377  N0390380  N0390382  N0390383  N0390385  N0390390  N0390393  N0392339  N0392343  N0392344  N0392345  N0392347  N0392349  N0392351  N0392353  N0392354  N0392355  N0392357  N0392360  N0392363  N0392364  N0392367  N0392368  N0392370  N0392372  N0392374  N0392375  N0397646  N0397796  N0397797  N0397798  N0397802  N0397803  N0397804  N0397805  N0397806  N0397807  N0397990  N0397993  N0397994  N0397996  N0397997  N0398016  N0398017  N0398019  N0398020  N0398021  N0396955  N0398306  N0405187  N0401002  N0396784  N0398527  N0400271  N0400917  N0407735  N0409318  N0398310  N0408255  N0399153  N0404847  N0398297  N0399447  N0403452  N0406065  N0409741  N0397353  N0398612  N0406345  N0408105  N0393498  N0395106  N0401234  N0402072  N0402652  N0406677  N0397637  N0400888  N0398823  N0399918  N0400676  N0404455  N0398592  N0409187  N0393520  N0394243  N0406426  N0407548  N0397583", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "FENTANYL, P.F. 100MCG/ML INJECTABLE 12 ML, 2 ML, 30 ML, 60 ML;  FENTANYL, P.F. 50MCG/ML (100MCG/2ML) INJECTABLE 100 ML, 120 ML, 150 ML, 20 ML,\t200 ML, 24 ML, 250 ML, 30 ML, 300 ML, 40 ML,\t400 ML, 50 ML, 60 ML; FENTANYL, WITH PRESERVATIVES 50MCG/ML INJECTABLE 30 ML (18 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1518-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:    0401908", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PHENYLEPHRINE/TROPICAMIDE (P.F.) SOLUTION 2.5%/1% OPHTHALMIC\t5 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1600-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Fountain Run", "address_1": "12954 Fountain Run Rd", "reason_for_recall": "Labeling Illegible: Some bottles labels have incomplete NDC numbers and missing strength.", "address_2": "", "product_quantity": "81,516 bottles", "code_info": "Lot: DL11600 Exp Date: 06/13", "center_classification_date": "20120919", "distribution_pattern": "Nationwide", "state": "KY", "product_description": "Enalapril Maleate Tablet, USP 5mg 30 Tablet bottle, Rx, Apace Packaging LLC, Ft. Run, KY 42133, NDC 15338-211-30", "report_date": "20120926", "classification": "Class III", "openfda": {}, "recalling_firm": "Apace KY LLC", "recall_number": "D-1683-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "63080", "termination_date": "20130710", "more_code_info": "", "recall_initiation_date": "20120904", "postal_code": "42133-7914", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pine Level", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62775", "recalling_firm": "Custom Medical Specialties, Inc.", "address_1": "330 East Main Street", "address_2": "N/A", "postal_code": "27568", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "FAX", "distribution_pattern": "GA, MD, MA", "recall_number": "D-1651-2012", "product_description": "CMS-2374-R4 Custom US Breast Core Biopsy Tray, Sterile, contains Sodium Chloride 0.9% 50 mL, Manufactured by: CMS Custom Medical Specialties, Inc., 330 East Main St, PO Box 177, Pine Level, NC 27568,  the tray also contains other components not listed in this product description.", "product_quantity": "25 Trays", "reason_for_recall": "Lack of Assurance of Sterility; the firm's medical trays contain Hospira's 0.9% Sodium Chloride bags which were subject to recall due to leaking bags.", "recall_initiation_date": "20120723", "center_classification_date": "20120817", "termination_date": "20121011", "report_date": "20120829", "code_info": "Lot #: 26124-1112, Exp 12/2012"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "62530", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-1655-2012", "product_description": "Daytrana (methylphenidate) transdermal system patch, Delivers 15 mg over 9 hours (1.6 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5553-3.", "product_quantity": "231,270 patches", "reason_for_recall": "Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.", "recall_initiation_date": "20120712", "center_classification_date": "20120817", "termination_date": "20140804", "report_date": "20120829", "code_info": "Lot #53823, Exp 08/12"}, {"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M027"], "brand_name": ["MIDOL COMPLETE"], "generic_name": ["MIDOL COMPLETE"], "manufacturer_name": ["Bayer HealthCare LLC"], "product_ndc": ["0280-8015"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "CAFFEINE", "PYRILAMINE MALEATE"], "rxcui": ["1597298"], "spl_id": ["0b61ed6d-b860-c5fc-e063-6394a90ab2a6"], "spl_set_id": ["0a4477ce-0a02-197d-e054-00144ff88e88"], "package_ndc": ["0280-8015-24"], "is_original_packager": [true], "upc": ["0312843172531"], "nui": ["N0000175739", "N0000175729", "N0000175790", "M0023046"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_cs": ["Xanthines [CS]"], "unii": ["362O9ITL9D", "3G6A5W338E", "R35D29L3ZA"]}, "product_type": "Drugs", "event_id": "61948", "recalling_firm": "Bayer Healthcare, LLC", "address_1": "36 Columbia Rd", "address_2": "", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 93 retail accounts/customers.", "recall_number": "D-1423-2012", "product_description": "Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Gelcaps 24 ct. blister, OTC,  Distributed by Bayer Health Care, Morristown, NJ 07962   NDC 0280-8015-24", "product_quantity": "119,412 cartons", "reason_for_recall": "Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.", "recall_initiation_date": "20120426", "center_classification_date": "20120719", "termination_date": "20140327", "report_date": "20120725", "code_info": "NAA04K6 Exp. 09/13, NAA055P Exp. 09/13, NAA05PA Exp. 09/13", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx #'s:N0393645  N0399634  N0398233  N0388437  N0395176  N0396644  N0403778  N0396442", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYDROMORPHONE P.F. 20MG/ML INTRATHECAL 40 ML; HYDROMORPHONE P.F. 25MG/ML INTRATHECAL 18 ML;  HYDROMORPHONE P.F. 30MG/ML INTRATHECAL 18 ML;  HYDROMORPHONE P.F. 50MG/ML INTRATHECAL 40 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1540-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "102 units", "code_info": "Rx #'s:    0396447      0391904    0396678    0393251    0400335      0402500    0352474    0368241    0387963                      0394942    0402089        0394942          0400335    0352474      0368241    0393251      0395043      0368241        0393251    0403936        0409994    0391904    0349660    0368241        0388163      0390614            0391904              0401994    0402332    0402500    0393985    0368241    0403168    0402227    0403032    0395193        0396679    0397454    0396679    0387480    0387514    0397147    0401881      0405105    0409255    0397147    0403630    0397147    0401846        0387647    0390992              0397147    0403742    0402848    0402848    0402848    0399288", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TRYPAN BLUE SOLUTION, P.F. 0.04% OPHTHALMIC\t10 ML;  \t  TRYPAN BLUE SOLUTION, P.F. 0.05% OPHTHALMIC\t0.5 ML  \t1.5 ML  \t10 ML  \t  \t  \t12 ML  \t2 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2.5 ML  \t  \t  \t  \t  \t3 ML  \t  \t  \t  \t  \t  \t  \t4 ML  \t  \t  \t  \t  \t  \t  \t  \t4.5 ML  \t5 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t6 ML  \t7.5 ML  \t8 ML;  TRYPAN BLUE SOLUTION, P.F. 0.06% OPHTHALMIC\t10 ML  \t  \t2.5 ML;  \t  \t  TRYPAN BLUE SOLUTION, P.F. 0.1% OPHTHALMIC\t1 ML  \t  \t1.5 ML  \t10 ML  \t  \t  \t  \t  \t  \t  \t12 ML  \t2 ML  \t25 ML  \t4 ML  \t  \t  \t5 ML  \t  \t  \t  \t  \t  \t  \t50 ML;  TRYPAN BLUE SOLUTION, P.F. STSL (0.5ML SYRINGE, NO NEEDLE) 0.06% OPHTHALMIC\t10 ML;  TRYPAN BLUE, 0.75ML SYRINGE, LUER-LOK, STSL 0.1% OPHTHALMIC\t3 ML  \t4.5 ML  \t9 ML;  TRYPAN BLUE, 1ML SYRINGE, LUER-LOK, STSL 0.1% OPHTHALMIC\t12 ML  (30 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1634-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "326 units", "code_info": "Rx #'s:  0366959    0388654    0388657    0388658    0388660    0388661    0388662    0388664    0388665    0388667    0388669    0388670    0388672    0388673    0390311    0390330    0390334    0390337    0390340    0390343    0390346    0390348    0390355    0390357    0390359    0390362    0391423    0391429    0391430    0391432    0391438    0391439    0391442    0391448    0391449    0391450    0391453    0391455    0391456    0391458    0391462    0391465    0391467    0391470    0395839    0395841    0395843    0395846    0395850    0395852    0395865    0395867    0395868    0395873    0395874    0395875    0397179    0397189    0397193    0397195    0397203    0397205    0397209    0397210    0397213    0397214    0397216    0397218    0397220    0397223    0397226    0397228    0397229    0399091    0399093    0399097    0399098    0399102    0399140    0399141    0399142    0399147    0399151    0399154    0399843    0399847    0399849    0399850    0399853    0399858    0399859    0399863    0399866    0399870    0399872    0399873    0399877    0399879    0399880    0399881    0402800    0402801    0402802    0402805    0402806    0402808    0402811    0402813    0402815    0402816    0402817    0402818    0402819    0402820    0402821    0402822    0402824    0404680    0404683    0404684    0404686    0404687    0404689    0404690    0404691    0404692    0404693    0404695    0404698    0404701    0404704    0405948    0405949    0405951    0405954    0405955    0405958    0405959    0405963    0405964    0405965    0405967    0405969    0406682    0406685    0406688    0406690    0406691    0406695    0406698    0406702    0406703    0406705    0406709    0406713    0406716    0406719    0406721    0406727    0409290    0409291    0409294    0409297    0409299    0409304    0409305    0409306    0409307    0409308    0409310    0409312    0409313    0409315    0409689    0409691    0409695    0409698    0409699    0409715    0409717    0409718    0409721    0409723    0409729    0409733    0363730        0369336      0382310    0387728    0389871    0394063    0357268      0366414    0398896      0367820      0387644      0370181    0387728    0397783    0367820    0394280    0366959    0397783    0400745    0366414    0387644            0397783      0397783    0369339      0387728    0367820    0382310    0352468    0394551      0406837    0397783    0386976    0398395    0358143            0397783          0372798          0385858      0397783    0367820    0386976    0398032    0385858        0367820      0382402    0395305    0384431        0387955      0397783    0392988", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYALURONIDASE - PRESERVATIVE FREE 150 U/ML INJECTABLE 1 MLS, 10 MLS, 100 MLS, 12 MLS, 12.5 ML, 120 MLS, 15 MLS, 16 ML,\t16 MLS, 2 MLS, 20 ML, 20 MLS, 24 MLS, 25 ML, 30 ML, 30 MLS, 36 MLS, 4 MLS, 40 MLS, 44 ML, 5 MLS, 50 ML, 50 MLS, 6 ML, 6 MLS, 60 MLS, 8 MLS, 80 MLS, 9 ML;  HYALURONIDASE - PRESERVATIVE FREE 200 U/ML INJECTABLE 2 MLS;  HYALURONIDASE / LIDOCAINE / BUPICAVAINE 7.1U/9.5MG/3.5MG/ML INJECTABLE 210 ML, 525 ML, 630 ML; HYALURONIDASE / LIDOCAINE 7.1U/9.5MG/ML INJECTABLE 105 ML, 210 ML; HYALURONIDASE 150 U/ML INJECTABLE 0.2 MLS, 0.3 MLS, 0.8 MLS, 1 MLS, 10 MLS, 12 MLS, 15 MLS, 20 MLS, 25 MLS, 3 ML, 4 ML, 40 MLS, 5 MLS, 50 MLS, 60 MLS,\t 8 MLS, 80 MLS;  HYALURONIDASE NO PRES 100 U/ML INJECTABLE 24 MLS, 40 MLS (48 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1534-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "16 units", "code_info": "Rx #'s: 0398691, 0401304, 0403533, 0385192, 0407592,   0394079, 0388572, 0391271, 0400529", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ACETYLCYSTEINE, OPHTHALMIC IN ARTIFICIAL TEARS 10% SOLUTION 10 ML, 2 ML, 5 ML, 6 ML; ACETYLCYSTEINE, OPHTHALMIC IN ARTIFICIAL TEARS 2.5% SOLUTION 20 ML; ACETYLCYSTEINE, OPHTHALMIC IN ARTIFICIAL TEARS 5% SOLUTION\t3 ML (6 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1449-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "", "code_info": "Rx #'s:   0369092      0390078      0388491        0404406    0399651    0373092", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "METHYLCOBALAMIN/FOLIC ACID - KIT 10MG/0.4MG/ML INJECTABLE\t1 KIT  \t  METHYLCOBALAMIN/FOLIC ACID 1000MCG/0.4MG/ML INJECTABLE\t10 ML  \t  METHYLCOBALAMIN/FOLIC ACID 10MG/0.4MG/ML INJECTABLE\t10 ML  \t  \t  \t  \t8 ML  \t8 MLS", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1574-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #:N0390025  N0399831", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE/SUFENTANIL, P.F. 15MG/150MCG/ML INTRATHECAL 20 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1479-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Sellersville", "address_1": "650 Cathill Rd", "reason_for_recall": "Impurities/Degradation:  This recall is being carried out due to the potential for some lots not meeting impurity specifications.", "address_2": "", "product_quantity": "100,761 cartons", "code_info": "Lot #'s 33800226A, Exp 7/2012; 33800333A, Exp 10/2012; 33800870A, Exp 10/2012; 33802533A, Exp 4/2013; and 33802720A, Exp 8/2013", "center_classification_date": "20120626", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "Zeosa (norethindrone and ethinyl estradiol tablets USP, (chewable), 0.4 mg/0.035 mg, and ferrous fumarate tablets USP, (chewable) 75 mg), 3 Blister Cards, 28 Tablets Each, Rx only, TEVA Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-2090-28 and 0093-2090-58, cartons containing three (3) individual blister packs", "report_date": "20120704", "classification": "Class II", "openfda": {}, "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "recall_number": "D-1397-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61776", "termination_date": "20130410", "more_code_info": "", "recall_initiation_date": "20120502", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:   0387998    0391766    0398634    0400173    0400383    0402841", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TETRACOSACTIDE ACETATE (COSYNTROPIN) 0.25MG/ML INJECTABLE\t1 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1623-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #:  0399969", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "INSULIN, LO-DOSE (FROM HUMALOG) 10 UNITS/ML INJECTABLE 10 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1547-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "107 units", "code_info": "Rx #'s:  0387683    0393065    0394633    0385938      0387683    0385222    0394375    0389789    0394526    0391261      0399698    0380189    0387389    0384308      0387389    0390830    0370011    0386507        0394133    0397580    0386507    0393521      0374071      0396478    0360399    0377887    0382420      0360399      0382420    0373839      0373839    0367517    0395929    0396303    0398978    0398980    0398983    0398987    0398061    0395908    0366449    0366449    0385953    0395908    0368413      0386587    0387945    0388529    0388631    0390720      0392250    0393056    0395446    0397146    0397459    0399806    0354531    0397967    0399668    0387481    0394553    0396177    0398687    0395424    0388631    0369860    0381370    0388529          0388631      0390143      0392319    0392455    0381370    0393958    0393960    0395294    0396324    0397146    0397149    0389458    0390143    0357319    0369209    0389845      0396123    0360125    0366749    0366749", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BRILLIANT BLUE G, P.F.  0.025% OPHTHALMIC 10 ML, 20 ML, 26 ML, 4 ML;  BRILLIANT BLUE G, P.F. (0.5ML SYRINGE) 0.25MG/ML OPHTHALMIC\t2 ML, 2.5 ML, 5 ML; BRILLIANT BLUE G, P.F. (0.5ML SYRINGE) 0.5MG/ML OPHTHALMIC 1.5 ML; BRILLIANT BLUE G, P.F. (0.5ML SYRINGE) 1% OPHTHALMIC 0.5 ML,1 ML,1.5 ML, 2 ML, 3 ML, 5 ML, 6 ML, 8 ML; BRILLIANT BLUE G, P.F. (STSL) (0.5ML SYRINGE) 0.025% OPHTHALMIC 2.5 ML, 5 ML;  BRILLIANT BLUE G, P.F. (STSL) (0.5ML SYRINGE) 0.15% OPHTHALMIC 2.5 ML; BRILLIANT BLUE G, P.F. 0.25% OPHTHALMIC 1 ML, 10 ML, 20 ML; BRILLIANT BLUE G, P.F. 0.5% OPHTHALMIC 1 ML, 10 ML,\t20 ML, 5 ML; BRILLIANT BLUE G, P.F. 1% OPHTHALMIC 10 ML, 12 ML, 15 ML, 2 ML, 2 MLS, 20 ., 20 ML, 30 ML, 4 ML, 40 ML, 50 ML, 6 ML, 80 ML, 9 ML; BRILLIANT BLUE G, P.F. 2% OPHTHALMIC 11 MLS, 15 MLS (43 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1468-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #:   0392274", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BIEST(80/20) 6.25MG/GM (1.25MG/0.2ML) I-CREAM 6 ML (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1465-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #'s:  0400853    0400853    0386510", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "RIBOFLAVIN SOLUTION 0.1% OPHTHALMIC\t10 ML  \t5 ML;  RIBOFLAVIN SOLUTION, P.F. 0.1% OPHTHALMIC\t90 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1613-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #'s:N0388659  N0392060  N0406634  N0406913  N0397272", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE/CLONIDINE/HYDROMORPHONE, P.F. 20MG/400MCG/2MG/ML INTRATHECAL; BUPIVACAINE/CLONIDINE/HYDROMORPHONE, P.F. 7.5MG/1.5MCG/50MG/ML INTRATHECAL; BUPIVACAINE/CLONIDINE/HYDROMORPHONE, P.F. 5MG/500MCG/50MG/ML INTRATHECAL (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1471-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:  0370408      0408889", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LEVOTHYROXINE SODIUM 325MCG/ML (0.325MG/ML) INJECTABLE\t15 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1557-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0408260", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MITOMYCIN/BUPIVACAINE WITH EPI 1:200,000 0. 04MG/0.5% PER 0.3ML SYR INJECTABLE\t3 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1582-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:   0368702            0368702", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CYCLOPENT/FLURBIPR/PHENYLEPH/PROPARACAINE .25%/0.0075%/0.625%/0.125% OPHTHALMIC 56 ML, 70 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1489-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "11 units", "code_info": "Rx #'s:    0374591    0374591              0391633    0391633    0374591", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TAURINE  50MG/ML INJECTABLE\t120 ML  \t30 ML  \t  \t  \t  \t  \t  \t  \t40 ML  \t60 ML  (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1620-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA072204"], "brand_name": ["LOXAPINE"], "generic_name": ["LOXAPINE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0369", "0591-0370", "0591-0371", "0591-0372"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOXAPINE SUCCINATE"], "rxcui": ["311385", "311386", "314075", "314078"], "spl_id": ["cae2db34-6be2-45cf-b9b5-9b929650eb4f"], "spl_set_id": ["a6107bb1-3e23-4c5d-bbf4-5e29deff6728"], "package_ndc": ["0591-0369-01", "0591-0370-01", "0591-0371-01", "0591-0372-01"], "is_original_packager": [true], "upc": ["0305910369019", "0305910370015", "0305910372019"], "unii": ["X59SG0MRYU"]}, "product_type": "Drugs", "event_id": "62383", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1402-2012", "product_description": "Loxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC #  0591-0372-01", "product_quantity": "18,902 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.", "recall_initiation_date": "20120417", "center_classification_date": "20120629", "termination_date": "20130318", "report_date": "20120711", "code_info": "Lot #s: 104432A, 104433A, 121344A, 127024A, 144290A"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62591", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "200 Somerset Corporate Blvd Fl 7th", "address_2": "N/A", "postal_code": "08807-2862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1435-2012", "product_description": "Dr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-127-05", "product_quantity": "1656 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets", "recall_initiation_date": "20120409", "center_classification_date": "20120731", "termination_date": "20130124", "report_date": "20120808", "code_info": "C201293  Exp Date 08/2013"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "134 units", "code_info": "Rx #'s:  0392321    0394025    0388514    0401919    0350642    0394025      0388514      0394025    0388514      0390732    0390733    0390734    0390735    0390736    0390737    0390738    0380350    0368327    0374556        0367241    0389528    0387672    0387673    0388017    0388019    0388022    0388506    0388512    0388515    0392608    0392615    0392616    0392619    0392621    0396198    0396215    0396216    0396229    0396231    0399438    0399439    0399442    0399445    0403009    0403010    0403011    0403012    0403013      0406259    0406260    0406262    0406344    0407979    0407983    0407994    0407995    0407997    0389528    0380350    0391097    0391097    0391097    0394711    0394711    0396280    0396282    0401229    0401451      0403261    0403264    0403265    0403266    0406344    0367241            0391097      0360638    0360913    0370332      0374556      0367241    0368572    0374556    0390415    0396119    0381037    0381037    0409349    0381037    0407487    0369244        0398000    0400203    0369244    0401228    0365406    0381433    0382639    0397201    0408640    0398000    0366257    0366257    0381433    0387899    0408486    0381433    0387899    0397201    0401228    0382639    0403456      0358087    0394872    0401833    0403472    0392320    0360357", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "INDOCYANINE GREEN - KIT 15MG INJECTABLE 1 KIT, 100 KIT, 12 KIT, 20 KIT,  50 KIT, 6 KIT, 75 KIT, 8 KIT; INDOCYANINE GREEN - KIT 1MG INJECTABLE 1 KIT, 10 `KIT, 10 KIT, 100 KIT, 18 VIAL, 2 KIT (51 DIFFERENT PRODUCTS)  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2 VIAL  \t20 KIT  \t22 KITS  \t25 KITS  \t3 KITS  \t3 VIALS  \t4 VIALS  \t5 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t50 KIT  \t  \t  \t  \t  \t50 KITS  \t  \t6 KIT  \t  \t  \t  \t  \t  \t60 KIT  \t8 KIT  \t  INDOCYANINE GREEN - KIT 25MG INJECTABLE\t1 KIT  \t6 KIT  INDOCYANINE GREEN - KIT 30MG INJECTABLE\t10 KIT  \t14 KIT  \t25 KIT  \t5 KIT  INDOCYANINE GREEN - KIT 5MG INJECTABLE\t1 KIT  \t10 KIT  \t  \t  \t  \t  \t12 KIT  \t15 KIT  \t15 VIAL  \t2 KIT  \t  \t  \t20 KIT  \t25 KIT  \t3 KIT  \t4 KIT  \t  \t  \t  \t5 KIT  \t  \t  \t  \t6 KIT  \t  \t  \t8 KIT  INDOCYANINE GREEN, LYOPHILIZED 15MG VIAL\t1 VIAL  INDOCYANINE GREEN, LYOPHILIZED 1MG VIAL\t2 VIAL  \t5 VIAL  INDOCYANINE GREEN, LYOPHILIZED 5MG VIAL\t1 VIAL  \t2 KIT", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1546-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Columbus", "address_1": "2550 John Glenn Ave Ste A", "reason_for_recall": "Labeling: Label Mix-Up: A typographical error in the product form on the carton label incorrectly lists the configuration as 30 \"Capsules\" (3 x 10) rather than \"Tablets\".", "address_2": "", "product_quantity": "1,170 cartons", "code_info": "Lot #: 113032A, 113032B, Exp 04/13", "center_classification_date": "20120814", "distribution_pattern": "Nationwide", "state": "OH", "product_description": "Topiramate Tablets, 50 mg, 30-count (3 x 10) unit-dose blisters per carton, Rx only, Mfd by: Cadila Healthcare Ltd., Ahmedabad, India; Dist By: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, Pkg by: American Health Packaging, Col. OH 43217, NDC 68084-343-21, blister barcode 6808434311", "report_date": "20120822", "classification": "Class III", "openfda": {}, "recalling_firm": "American Health Packaging", "recall_number": "D-1645-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62792", "termination_date": "20130702", "more_code_info": "", "recall_initiation_date": "20120725", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "61871", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Ohio", "recall_number": "D-1409-2012", "product_description": "Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10", "product_quantity": "2,268 bottles", "reason_for_recall": "Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)", "recall_initiation_date": "20120516", "center_classification_date": "20120705", "termination_date": "20130322", "report_date": "20120711", "code_info": "Lot #TE1Y261, Exp, 12/2013"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "47 units", "code_info": "Rx #'s:  0389833    0394741          0392912    0388244          0397159    0399176      0388244    0405177    0409379    0392912      0397159    0377235    0408837    0402247    0388244      0397159        0403342    0404418    0388244            0393276    0393276    0351537      0393276    0351537    0393276            0390499", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "GLUTATHIONE INHALATION  30MG/ML SOLUTION 120 ML, 60 ML; GLUTATHIONE P.F. 200MG/ML   INJECTABLE\t10 ML, 100 ML, 14 ML, 150 ML, 175 ML, 20 ML, 30 ML, 300 ML, 40 ML, 40 MLS, 50 ML, 58 MLS, 70 ML;\t  GLUTATHIONE P.F. 50MG/ML (500MG/10ML) INJECTABLE 100 ML, 150 ML, 20 ML, 40 ML,  60 ML; GLUTATHIONE-FFC  100MG/ML   INJECTABLE 20 ML (21 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1529-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Monroe Township", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021357"], "brand_name": ["MULTIHANCE"], "generic_name": ["GADOBENATE DIMEGLUMINE"], "manufacturer_name": ["BRACCO DIAGNOSTICS INC"], "product_ndc": ["0270-5164"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["GADOBENATE DIMEGLUMINE"], "spl_id": ["0e7d3da8-78fa-b4ae-4a43-15919e900ebe"], "spl_set_id": ["59077a3e-5f03-4342-ae24-856267545631"], "package_ndc": ["0270-5164-12", "0270-5164-13", "0270-5164-14", "0270-5164-15"], "is_original_packager": [true], "unii": ["3Q6PPC19PO"]}, "product_type": "Drugs", "event_id": "62636", "recalling_firm": "Bracco Diagnostics Inc", "address_1": "259 Prospect Plains Rd.", "address_2": "Building H", "postal_code": "08831", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1663-2012", "product_description": "Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15", "product_quantity": "47,750 vials", "reason_for_recall": "Short Fill:  The product is being recalled due to a potential underfill of the affected vials.", "recall_initiation_date": "20120416", "center_classification_date": "20120827", "termination_date": "20130708", "report_date": "20120905", "code_info": "Lot S1P272A  Expiry Date: December 2014"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:   0382804    0356180", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "L-ARGININE  500MG/ML INJECTABLE\t2500 ML  \t500 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1554-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Huntsville", "address_1": "120 Vintage Dr NE", "reason_for_recall": "Impurities/Degradation Products: Out of specificiation results for impurities at the 18-month room temperature time point.", "address_2": "", "product_quantity": "54,431 bottles", "code_info": "Lot #:  L072B11A, Exp 8/12; L102C11A, L103C11A, Exp 10/12; L046D11A, L082F11A, L089F11A, Exp 11/12; L148J11A, L149J11A, L150J11A, Exp 03/13; and L151J11A, Exp 04/13", "center_classification_date": "20120711", "distribution_pattern": "Nationwide and Puerto Rico.", "state": "AL", "product_description": "HYDROCORTISONE and ACETIC ACID OTIC SOLUTION, USP, 10 mL bottle, Rx only, Mfg. for:  QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811; NDC 0603-7039-39; UPC 3 0603-7039-39 7.", "report_date": "20120718", "classification": "Class III", "openfda": {}, "recalling_firm": "Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals", "recall_number": "D-1411-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62496", "termination_date": "20130201", "more_code_info": "", "recall_initiation_date": "20120706", "postal_code": "35811-8216", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]